Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:ortho-fused heteroarene
go back to main search page
Accession:CHEBI:52362 term browser browse the term
Definition:An ortho-fused compound in which at least one of the rings contains at least one heteroatom.
Synonyms:related_synonym: ortho-fused heteroarenes


show annotations for term's descendants           Sort by:
 
1H-indole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
multiple interactions		 ISO indole results in increased expression of ABCB1 mRNA
indole promotes the reaction [NR1I2 protein binds to ABCB1 promoter]; NR1I2 protein promotes the reaction [indole results in increased expression of ABCB1 mRNA]		 CTD PMID:33002526 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions ISO indole binds to and results in increased activity of AHR protein; indole results in increased activity of [AHR protein binds to ARNT protein] CTD PMID:9407059 PMID:28186253 NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO indole results in increased activity of [AHR protein binds to ARNT protein] CTD PMID:9407059 NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases expression		 ISO NR1I2 protein promotes the reaction [indole results in increased expression of CYP3A4 mRNA] CTD PMID:33002526 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Epo erythropoietin multiple interactions EXP indole inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA]; indole inhibits the reaction [cobaltous chloride results in increased expression of EPO protein] CTD PMID:21863063 NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946 		JBrowse link
G Mc1r melanocortin 1 receptor affects binding ISO indole analog binds to MC1R protein CTD PMID:11909711 NCBI chr19:51,452,448...51,455,375 JBrowse link
G Mc3r melanocortin 3 receptor affects binding ISO indole analog binds to MC3R protein CTD PMID:11909711 NCBI chr 3:161,016,347...161,017,444
Ensembl chr 3:161,016,347...161,017,444 		JBrowse link
G Mc4r melanocortin 4 receptor affects binding ISO indole analog binds to MC4R protein CTD PMID:11909711 NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719 		JBrowse link
G Mc5r melanocortin 5 receptor affects binding ISO indole analog binds to MC5R protein CTD PMID:11909711 NCBI chr18:61,915,188...61,920,229
Ensembl chr18:61,915,188...61,920,229 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO indole binds to and results in increased activity of NR1I2 protein; indole promotes the reaction [NR1I2 protein binds to ABCB1 promoter]; NR1I2 protein promotes the reaction [indole results in increased expression of ABCB1 mRNA]; NR1I2 protein promotes the reaction [indole results in increased expression of CYP3A4 mRNA] CTD PMID:33002526 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
2-methyl-1H-indole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO 2-methylindole results in increased expression of ABCB1 mRNA CTD PMID:32092453 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions		 ISO 2-methylindole results in increased expression of CYP1A1 protein
2-methylindole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]		 CTD PMID:31201936 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO 2-methylindole results in increased expression of CYP1A2 protein CTD PMID:31201936 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions		 ISO 2-methylindole results in increased expression of CYP3A4 mRNA
NR1I2 protein affects the reaction [2-methylindole results in increased expression of CYP3A4 mRNA]		 CTD PMID:32092453 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 affects binding
multiple interactions
increases expression		 ISO 2-methylindole binds to NR1I2 protein
NR1I2 protein affects the reaction [2-methylindole results in increased expression of CYP3A4 mRNA]
2-methylindole results in increased expression of NR1I2 mRNA		 CTD PMID:32092453 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
6,7-dimethoxy-2-phenylquinoxaline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] CTD PMID:25896968 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] CTD PMID:25896968 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein] CTD PMID:25896968 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFB mRNA]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased secretion of PDGFB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline results in decreased susceptibility to [PDGFB protein binds to PDGFB protein] CTD PMID:16149045 PMID:23457620 PMID:25896968 NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984 		JBrowse link
G Pdgfrb platelet derived growth factor receptor beta multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] CTD PMID:16149045 PMID:25896968 NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843 		JBrowse link
6-Cyano-7-nitroquinoxaline-2,3-dione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aco2 aconitase 2 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Kainic Acid results in decreased activity of ACO2 protein] CTD PMID:11520895 NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA alternative form] CTD PMID:15183516 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]] CTD PMID:24995437 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased expression of FOS] CTD PMID:10401552 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA1 protein CTD PMID:19674091 NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA2 protein CTD PMID:19674091 NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO
EXP		 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]		 CTD PMID:15385614 PMID:19850060 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO
EXP		 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]		 CTD PMID:15385614 PMID:19850060 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Nefl neurofilament light chain multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [N-Methylaspartate results in decreased expression of NEFL mRNA]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:21863293 PMID:31969611 NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793 		JBrowse link
G Nefm neurofilament medium chain multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein] CTD PMID:21863293 NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755 		JBrowse link
G Sct secretin multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [SCT protein results in increased secretion of gamma-Aminobutyric Acid] CTD PMID:15963647 NCBI chr 1:196,382,941...196,383,635
Ensembl chr 1:196,382,856...196,383,658 		JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [L 703606 results in increased activity of TAC1 protein] CTD PMID:14985054 NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178 		JBrowse link
G Vim vimentin multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein] CTD PMID:21863293 NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187 		JBrowse link
brimonidine tartrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra2a adrenoceptor alpha 2A multiple interactions ISO
EXP		 Brimonidine Tartrate inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein]; Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]; Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]] CTD PMID:8397342 PMID:10742289 PMID:12208771 PMID:12598592 NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365 		JBrowse link
G Agt angiotensinogen multiple interactions EXP 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] CTD PMID:18250367 NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977 		JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions ISO Brimonidine Tartrate inhibits the reaction [CFTR protein affects the transport of Chlorides] CTD PMID:12598592 NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases phosphorylation EXP Brimonidine Tartrate results in increased phosphorylation of CREB1 protein CTD PMID:17680988 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816 		JBrowse link
G Prkca protein kinase C, alpha affects localization
multiple interactions		 EXP Brimonidine Tartrate affects the localization of PRKCA protein
Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein]		 CTD PMID:12388232 NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012 		JBrowse link
G Prkcd protein kinase C, delta affects localization
multiple interactions		 EXP Brimonidine Tartrate affects the localization of PRKCD protein
Nitric Oxide deficiency inhibits the reaction [Brimonidine Tartrate affects the localization of PRKCD protein]		 CTD PMID:12388232 NCBI chr16:5,769,226...5,807,214
Ensembl chr16:5,769,215...5,799,352 		JBrowse link
G Rhoa ras homolog family member A multiple interactions EXP 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] CTD PMID:18250367 NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Brimonidine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268 		JBrowse link
Carbadox term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression EXP Carbadox results in increased expression of CDKN1A mRNA; Carbadox results in increased expression of CDKN1A protein CTD PMID:26558467 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression EXP Carbadox results in increased expression of MDM2 mRNA CTD PMID:26558467 NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression EXP Carbadox results in decreased expression of MKI67 protein CTD PMID:26558467 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762 		JBrowse link
G Top2a DNA topoisomerase II alpha decreases expression EXP Carbadox results in decreased expression of TOP2A protein CTD PMID:26558467 NCBI chr10:83,946,186...83,975,694
Ensembl chr10:83,945,735...83,976,874 		JBrowse link
cyclazosin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra1b adrenoceptor alpha 1B multiple interactions EXP cyclazosin binds to and results in decreased activity of ADRA1B protein CTD PMID:15951348 NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919 		JBrowse link
enoxacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
affects binding
decreases activity		 ISO
EXP		 Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine]; Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]; NADP promotes the reaction [Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]]
Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]
Enoxacin binds to CYP1A2 protein
Enoxacin results in decreased activity of CYP1A2 protein		 CTD PMID:7946932 PMID:8905919 PMID:15905806 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO Enoxacin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 affects binding ISO Enoxacin binds to KCNH2 protein CTD PMID:34058295 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions ISO 7-nitroindazole inhibits the reaction [[Enoxacin co-treated with fenbufen] results in increased activity of NOS1 protein]; [Enoxacin co-treated with fenbufen] results in increased activity of NOS1 protein CTD PMID:9623721 NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945 		JBrowse link
hydralazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb5 ATP binding cassette subfamily B member 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ABCB5 mRNA CTD PMID:17183730 NCBI chr 6:139,836,528...139,932,830
Ensembl chr 6:139,835,949...139,932,830 		JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACAA1 mRNA CTD PMID:17183730 NCBI chr 8:119,079,401...119,088,624
Ensembl chr 8:119,079,775...119,088,624 		JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACAD9 mRNA CTD PMID:17183730 NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACAT2 mRNA CTD PMID:17183730 NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821 		JBrowse link
G Ace angiotensin I converting enzyme multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACE mRNA] CTD PMID:16326922 NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACIN1 mRNA CTD PMID:17183730 NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001 		JBrowse link
G Acot2 acyl-CoA thioesterase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ACOT2 mRNA CTD PMID:17183730 NCBI chr 6:103,611,744...103,619,404
Ensembl chr 6:103,611,544...103,619,245 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACTA1 mRNA] CTD PMID:16326922 NCBI chr19:51,883,713...51,886,725
Ensembl chr19:51,883,715...51,886,742 		JBrowse link
G Adamts10 ADAM metallopeptidase with thrombospondin type 1 motif, 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADAMTS10 mRNA CTD PMID:17183730 NCBI chr 7:14,331,659...14,361,620
Ensembl chr 7:14,331,745...14,361,620 		JBrowse link
G Adgra3 adhesion G protein-coupled receptor A3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADGRA3 mRNA CTD PMID:17183730 NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332 		JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADIPOR1 mRNA CTD PMID:17183730 NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241 		JBrowse link
G Adsl adenylosuccinate lyase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADSL mRNA CTD PMID:17183730 NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760 		JBrowse link
G Afg3l2 AFG3 like matrix AAA peptidase subunit 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AFG3L2 mRNA CTD PMID:17183730 NCBI chr18:60,954,268...60,999,110
Ensembl chr18:60,954,268...60,999,110 		JBrowse link
G Agk acylglycerol kinase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AGK mRNA CTD PMID:17183730 NCBI chr 4:69,114,850...69,193,989
Ensembl chr 4:69,114,269...69,193,934 		JBrowse link
G Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of AGPAT2 mRNA CTD PMID:17183730 NCBI chr 3:9,416,842...9,428,567
Ensembl chr 3:9,416,843...9,428,371 		JBrowse link
G Agt angiotensinogen multiple interactions
decreases response to substance		 EXP
ISO		 Hydralazine affects the reaction [AGT protein results in increased abundance of Fatty Acids, Nonesterified]; Hydralazine affects the reaction [AGT protein results in increased abundance of Triglycerides]; Hydralazine inhibits the reaction [AGT protein affects the abundance of Cholesterol]; Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK1 protein]; Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK3 protein]; Hydralazine inhibits the reaction [AGT protein results in decreased expression of CPT1A mRNA]
Hydralazine results in decreased susceptibility to AGT protein modified form		 CTD PMID:16344371 PMID:19109942 PMID:21289285 NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1A1 mRNA CTD PMID:17183730 NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C4 mRNA CTD PMID:17183730 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA CTD PMID:17183730 NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKT2 mRNA CTD PMID:17183730 NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817 		JBrowse link
G Alb albumin multiple interactions
affects binding		 ISO Hydralazine inhibits the reaction [[Acrolein binds to ALB protein] which results in increased expression of HMOX1 mRNA]
Hydralazine binds to [Acrolein binds to ALB protein]		 CTD PMID:32530271 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH18A1 mRNA CTD PMID:17183730 NCBI chr 1:239,375,657...239,407,967
Ensembl chr 1:239,375,669...239,407,890 		JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH9A1 mRNA CTD PMID:17183730 NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ALOX15 mRNA CTD PMID:17183730 NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874 		JBrowse link
G Anapc11 anaphase promoting complex subunit 11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANAPC11 mRNA CTD PMID:17183730 NCBI chr10:105,875,209...105,886,307 JBrowse link
G Ankfn1 ankyrin-repeat and fibronectin type III domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKFN1 mRNA CTD PMID:17183730 NCBI chr10:74,214,143...74,602,825 JBrowse link
G Ankhd1 ankyrin repeat and KH domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKHD1 mRNA CTD PMID:17183730 NCBI chr18:28,161,882...28,260,917 JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKIB1 mRNA CTD PMID:17183730 NCBI chr 4:30,333,678...30,457,781
Ensembl chr 4:30,333,677...30,457,781 		JBrowse link
G Ankrd44 ankyrin repeat domain 44 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKRD44 mRNA CTD PMID:17183730 NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508 		JBrowse link
G Anxa2 annexin A2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANXA2 mRNA CTD PMID:17183730 NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658 		JBrowse link
G Aoah acyloxyacyl hydrolase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of AOAH mRNA CTD PMID:17183730 NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148 		JBrowse link
G Aoc1 amine oxidase, copper containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AOC1 mRNA CTD PMID:17183730 NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases methylation ISO Hydralazine results in decreased methylation of APC promoter CTD PMID:15862127 NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696 		JBrowse link
G Apcdd1l APC down-regulated 1 like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of APCDD1L mRNA CTD PMID:17183730 NCBI chr 3:162,587,484...162,658,362
Ensembl chr 3:162,582,252...162,658,073 		JBrowse link
G Arcn1 archain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARCN1 mRNA CTD PMID:17183730 NCBI chr 8:45,057,617...45,082,224
Ensembl chr 8:45,057,619...45,082,247 		JBrowse link
G Arf1 ADP-ribosylation factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARF1 mRNA CTD PMID:17183730 NCBI chr10:43,997,983...44,014,543
Ensembl chr10:43,997,986...44,014,434 		JBrowse link
G Arhgap23 Rho GTPase activating protein 23 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP23 mRNA CTD PMID:17183730 NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,394,648...82,496,504 		JBrowse link
G Arhgap40 Rho GTPase activating protein 40 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP40 mRNA CTD PMID:17183730 NCBI chr 3:147,203,042...147,206,546
Ensembl chr 3:147,165,729...147,207,203 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP5 mRNA CTD PMID:17183730 NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660 		JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA CTD PMID:17183730 NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366 		JBrowse link
G Arih2 ariadne RBR E3 ubiquitin protein ligase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARIH2 mRNA CTD PMID:17183730 NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852 		JBrowse link
G Arl2 ADP-ribosylation factor like GTPase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL2 mRNA CTD PMID:17183730 NCBI chr 1:203,434,129...203,446,156
Ensembl chr 1:203,434,129...203,446,119 		JBrowse link
G Arl6ip5 ADP-ribosylation factor like GTPase 6 interacting protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA CTD PMID:17183730 NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608 		JBrowse link
G Art4 ADP-ribosyltransferase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ART4 mRNA CTD PMID:17183730 NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665 		JBrowse link
G Asap3 ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDEFL1 mRNA CTD PMID:17183730 NCBI chr 5:148,433,382...148,476,027
Ensembl chr 5:148,433,494...148,474,073 		JBrowse link
G Asb7 ankyrin repeat and SOCS box-containing 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ASB7 mRNA CTD PMID:17183730 NCBI chr 1:120,222,835...120,267,411
Ensembl chr 1:120,222,745...120,267,282 		JBrowse link
G Asic4 acid sensing ion channel subunit family member 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ASIC4 mRNA CTD PMID:17183730 NCBI chr 9:76,941,532...76,962,900
Ensembl chr 9:76,941,532...76,962,900 		JBrowse link
G Asph aspartate-beta-hydroxylase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ASPH mRNA CTD PMID:17183730 NCBI chr 5:22,603,879...22,814,107
Ensembl chr 5:22,603,486...22,813,876 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of ATF3 mRNA] CTD PMID:28119953 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of ATF4 mRNA] CTD PMID:28119953 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Atg10 autophagy related 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATG10 mRNA CTD PMID:17183730 NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233 		JBrowse link
G Atp13a4 ATPase 13A4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP13A4 mRNA CTD PMID:17183730 NCBI chr11:71,222,196...71,359,933
Ensembl chr11:71,226,161...71,359,933 		JBrowse link
G Atp5f1e ATP synthase F1 subunit epsilon multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5F1E mRNA CTD PMID:17183730 NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450 		JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5MC3 mRNA CTD PMID:17183730 NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279 		JBrowse link
G Atp5me ATP synthase membrane subunit e multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5ME mRNA CTD PMID:17183730 NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013 		JBrowse link
G Atp5pf ATP synthase peripheral stalk subunit F6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5PF mRNA CTD PMID:17183730 NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119 		JBrowse link
G Atp6ap1 ATPase H+ transporting accessory protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP6AP1 mRNA CTD PMID:17183730 NCBI chr  X:152,079,954...152,087,034
Ensembl chr  X:152,079,865...152,087,034 		JBrowse link
G Atp6v1b1 ATPase H+ transporting V1 subunit B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP6V1B1 mRNA CTD PMID:17183730 NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475 		JBrowse link
G Atp6v1c1 ATPase H+ transporting V1 subunit C1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP6V1C1 mRNA CTD PMID:17183730 NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278 		JBrowse link
G Atxn2 ataxin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN2 mRNA CTD PMID:17183730 NCBI chr12:34,754,132...34,851,175
Ensembl chr12:34,754,137...34,851,479 		JBrowse link
G Atxn7l1 ataxin 7-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN7L1 mRNA CTD PMID:17183730 NCBI chr 6:49,759,876...49,982,323
Ensembl chr 6:49,759,883...49,982,320 		JBrowse link
G Aurkaip1 aurora kinase A interacting protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AURKAIP1 mRNA CTD PMID:17183730 NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882 		JBrowse link
G B9d1 B9 domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of B9D1 mRNA CTD PMID:17183730 NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BAD mRNA CTD PMID:17183730 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823 		JBrowse link
G Bag1 BAG cochaperone 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BAG1 mRNA CTD PMID:17183730 NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075 		JBrowse link
G Bckdk branched chain ketoacid dehydrogenase kinase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BCKDK mRNA CTD PMID:17183730 NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633 		JBrowse link
G Bola1 bolA family member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BOLA1 mRNA CTD PMID:17183730 NCBI chr 2:183,758,515...183,771,445
Ensembl chr 2:183,758,441...183,781,576 		JBrowse link
G Bpgm bisphosphoglycerate mutase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BPGM mRNA CTD PMID:17183730 NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581 		JBrowse link
G Bpifb2 BPI fold containing family B, member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BPIFB2 mRNA CTD PMID:17183730 NCBI chr 3:142,356,990...142,377,053
Ensembl chr 3:142,358,051...142,377,044 		JBrowse link
G Bptf bromodomain PHD finger transcription factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BPTF mRNA CTD PMID:17183730 NCBI chr10:91,980,279...92,082,731
Ensembl chr10:91,982,758...92,082,769 		JBrowse link
G Brd8 bromodomain containing 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BRD8 mRNA CTD PMID:17183730 NCBI chr18:26,181,744...26,230,035
Ensembl chr18:26,181,732...26,229,884 		JBrowse link
G C1qtnf5 C1q and TNF related 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C1QTNF5 mRNA CTD PMID:17183730 NCBI chr 8:44,450,934...44,453,075
Ensembl chr 8:44,451,154...44,453,074 		JBrowse link
G C4a complement C4A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C4A mRNA CTD PMID:17183730 NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080 		JBrowse link
G Ca8 carbonic anhydrase 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of CA8 mRNA CTD PMID:17183730 NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374 		JBrowse link
G Cacng6 calcium voltage-gated channel auxiliary subunit gamma 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CACNG6 mRNA CTD PMID:17183730 NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341 		JBrowse link
G Camlg calcium modulating ligand multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CAMLG mRNA CTD PMID:17183730 NCBI chr17:8,992,697...9,003,576
Ensembl chr17:8,992,696...9,003,552 		JBrowse link
G Canx calnexin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CANX mRNA CTD PMID:17183730 NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821 		JBrowse link
G Car7 carbonic anhydrase 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CA7 mRNA CTD PMID:17183730 NCBI chr19:429,063...438,478
Ensembl chr19:429,075...438,467 		JBrowse link
G Casd1 CAS1 domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CASD1 mRNA CTD PMID:17183730 NCBI chr 4:32,658,888...32,739,224
Ensembl chr 4:32,658,748...32,739,202 		JBrowse link
G Casp12 caspase 12 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased cleavage of CASP12 protein] CTD PMID:28119953 NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037 		JBrowse link
G Cbx7 chromobox 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CBX7 mRNA CTD PMID:17183730 NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973 		JBrowse link
G Ccdc138 coiled-coil domain containing 138 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCDC138 mRNA CTD PMID:17183730 NCBI chr20:26,493,624...26,572,367
Ensembl chr20:26,495,235...26,572,376 		JBrowse link
G Ccdc146 coiled-coil domain containing 146 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of CCDC146 mRNA CTD PMID:17183730 NCBI chr 4:13,662,766...13,811,619
Ensembl chr 4:13,662,766...13,811,608 		JBrowse link
G Ccdc47 coiled-coil domain containing 47 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCDC47 mRNA CTD PMID:17183730 NCBI chr10:91,130,303...91,148,829
Ensembl chr10:91,130,303...91,148,881 		JBrowse link
G Ccdc82 coiled-coil domain containing 82 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCDC82 mRNA CTD PMID:17183730 NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963 		JBrowse link
G Ccl22 C-C motif chemokine ligand 22 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL22 mRNA CTD PMID:17183730 NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL28 mRNA CTD PMID:17183730 NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL4 mRNA CTD PMID:17183730 NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231 		JBrowse link
G Ccm2 CCM2 scaffold protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCM2 mRNA CTD PMID:17183730 NCBI chr14:81,418,418...81,464,114
Ensembl chr14:81,418,236...81,464,116 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCT2 mRNA CTD PMID:17183730 NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944 		JBrowse link
G Cct7 chaperonin containing TCP1 subunit 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCT7 mRNA CTD PMID:17183730 NCBI chr 4:117,989,232...118,006,478
Ensembl chr 4:117,989,232...118,006,580 		JBrowse link
G Ccz1b CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCZ1B mRNA CTD PMID:17183730 NCBI chr12:10,601,066...10,624,608
Ensembl chr12:10,601,056...10,624,608 		JBrowse link
G Cd63 Cd63 molecule multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CD63 mRNA CTD PMID:17183730 NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178 		JBrowse link
G Cdadc1 cytidine and dCMP deaminase domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDADC1 mRNA CTD PMID:17183730 NCBI chr15:33,726,590...33,755,611
Ensembl chr15:33,723,435...33,755,576 		JBrowse link
G Cdc37 cell division cycle 37, HSP90 cochaperone multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDC37 mRNA CTD PMID:17183730 NCBI chr 8:19,677,400...19,690,761
Ensembl chr 8:19,671,938...19,690,809 		JBrowse link
G Cdc42 cell division cycle 42 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDC42 mRNA CTD PMID:17183730 NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111 		JBrowse link
G Cdk12 cyclin-dependent kinase 12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDK12 mRNA CTD PMID:17183730 NCBI chr10:83,201,177...83,256,906
Ensembl chr10:83,201,211...83,280,888 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDK4 mRNA CTD PMID:17183730 NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions EXP [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions
decreases methylation		 EXP
ISO		 [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA]
Hydralazine results in decreased methylation of CDKN2A promoter		 CTD PMID:15862127 PMID:18504326 NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149 		JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDR2 mRNA CTD PMID:17183730 NCBI chr 1:175,502,837...175,527,746
Ensembl chr 1:175,502,838...175,537,472 		JBrowse link
G Cel carboxyl ester lipase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CEL mRNA CTD PMID:17183730 NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035 		JBrowse link
G Cenpn centromere protein N multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CENPN mRNA CTD PMID:17183730 NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012 		JBrowse link
G Cers5 ceramide synthase 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CERS5 mRNA CTD PMID:17183730 NCBI chr 7:130,859,993...130,897,979
Ensembl chr 7:130,859,990...130,897,947 		JBrowse link
G Cfap300 cilia and flagella associated protein 300 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CFAP300 mRNA CTD PMID:17183730 NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807 		JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHCHD10 mRNA CTD PMID:17183730 NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763 		JBrowse link
G Chchd2 coiled-coil-helix-coiled-coil-helix domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHCHD2 mRNA CTD PMID:17183730 NCBI chr 9:94,500,439...94,501,110
Ensembl chr 9:94,500,432...94,501,128 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHD2 mRNA CTD PMID:17183730 NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502 		JBrowse link
G Chmp5 charged multivesicular body protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHMP5 mRNA CTD PMID:17183730 NCBI chr 5:56,081,385...56,098,529
Ensembl chr 5:56,081,343...56,098,529 		JBrowse link
G Chn2 chimerin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHN2 mRNA CTD PMID:17183730 NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709 		JBrowse link
G Chrna1 cholinergic receptor nicotinic alpha 1 subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHRNA1 mRNA CTD PMID:17183730 NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840 		JBrowse link
G Chst13 carbohydrate sulfotransferase 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHST13 mRNA CTD PMID:17183730 NCBI chr 4:122,824,712...122,837,935
Ensembl chr 4:122,824,022...122,838,019 		JBrowse link
G Cib1 calcium and integrin binding 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CIB1 mRNA CTD PMID:17183730 NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423 		JBrowse link
G Clasp2 cytoplasmic linker associated protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CLASP2 mRNA CTD PMID:17183730 NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731 		JBrowse link
G Clcn5 chloride voltage-gated channel 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CLCN5 mRNA CTD PMID:17183730 NCBI chr  X:15,185,353...15,339,977
Ensembl chr  X:15,185,451...15,334,264 		JBrowse link
G Clybl citramalyl-CoA lyase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA CTD PMID:17183730 NCBI chr15:99,283,644...99,505,697
Ensembl chr15:99,283,650...99,505,695 		JBrowse link
G Cnnm3 cyclin and CBS domain divalent metal cation transport mediator 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CNNM3 mRNA CTD PMID:17183730 NCBI chr 9:38,755,374...38,770,740
Ensembl chr 9:38,755,390...38,770,740 		JBrowse link
G Coa3 cytochrome C oxidase assembly factor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COA3 mRNA CTD PMID:17183730 NCBI chr10:86,220,192...86,221,173
Ensembl chr10:86,220,194...86,221,178 		JBrowse link
G Cog5 component of oligomeric golgi complex 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COG5 mRNA CTD PMID:17183730 NCBI chr 6:48,242,470...48,545,185
Ensembl chr 6:48,242,482...48,529,009 		JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression
multiple interactions		 ISO Hydralazine results in decreased expression of COL1A1 mRNA
[Hydralazine co-treated with Valproic Acid] results in increased expression of COL1A1 mRNA		 CTD PMID:8941590 PMID:17183730 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Col4a6 collagen type IV alpha 6 chain multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COL4A6 mRNA CTD PMID:17183730 NCBI chr  X:104,766,463...105,117,499
Ensembl chr  X:104,766,957...105,117,500 		JBrowse link
G Commd1 copper metabolism domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COMMD1 mRNA CTD PMID:17183730 NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501 		JBrowse link
G Commd6 COMM domain containing 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COMMD6 mRNA CTD PMID:17183730 NCBI chr15:78,467,333...78,474,382
Ensembl chr15:78,467,804...78,474,382 		JBrowse link
G Cope COPI coat complex subunit epsilon multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COPE mRNA CTD PMID:17183730 NCBI chr16:19,114,871...19,125,527
Ensembl chr16:19,114,871...19,128,907 		JBrowse link
G Cops4 COP9 signalosome subunit 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COPS4 mRNA CTD PMID:17183730 NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,078,576...9,108,887 		JBrowse link
G Coq4 coenzyme Q4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COQ4 mRNA CTD PMID:17183730 NCBI chr 3:13,060,054...13,070,502
Ensembl chr 3:13,060,455...13,068,799 		JBrowse link
G Cox6b1 cytochrome c oxidase subunit 6B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COX6B1 mRNA CTD PMID:17183730 NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 		JBrowse link
G Cox7c cytochrome c oxidase subunit 7C multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COX7C mRNA CTD PMID:17183730 NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions EXP Hydralazine inhibits the reaction [AGT protein results in decreased expression of CPT1A mRNA] CTD PMID:19109942 NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Creb5 cAMP responsive element binding protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CREB5 mRNA CTD PMID:17183730 NCBI chr 4:82,393,091...82,794,320
Ensembl chr 4:82,393,730...82,790,325 		JBrowse link
G Cryba4 crystallin, beta A4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CRYBA4 mRNA CTD PMID:17183730 NCBI chr12:44,378,734...44,393,226
Ensembl chr12:44,378,737...44,393,221 		JBrowse link
G Ctcf CCCTC-binding factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of CTCF mRNA CTD PMID:17183730 NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123 		JBrowse link
G Ctnnd1 catenin delta 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CTNND1 mRNA CTD PMID:17183730 NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516 		JBrowse link
G Ctsk cathepsin K multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CTSK mRNA CTD PMID:17183730 NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550 		JBrowse link
G Cuedc2 CUE domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CUEDC2 mRNA CTD PMID:17183730 NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339 		JBrowse link
G Cul1 cullin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CUL1 mRNA CTD PMID:17183730 NCBI chr 4:76,551,952...76,625,830
Ensembl chr 4:76,551,983...76,627,980 		JBrowse link
G Cyb5r1 cytochrome b5 reductase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R1 mRNA CTD PMID:17183730 NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R3 mRNA CTD PMID:17183730 NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA CTD PMID:17183730 NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions EXP
ISO		 Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] CTD PMID:18493746 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO
EXP		 Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYP2A7 mRNA CTD PMID:17183730 NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979 		JBrowse link
G Cyp4x1 cytochrome P450, family 4, subfamily x, polypeptide 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYP4X1 mRNA CTD PMID:17183730 NCBI chr 5:128,652,844...128,683,338
Ensembl chr 5:128,651,776...128,682,779 		JBrowse link
G Dact2 dishevelled-binding antagonist of beta-catenin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DACT2 mRNA CTD PMID:17183730 NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096 		JBrowse link
G Dancr differentiation antagonizing non-protein coding RNA multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DANCR mRNA CTD PMID:17183730 NCBI chr14:34,126,956...34,127,936 JBrowse link
G Dapk1 death associated protein kinase 1 decreases methylation
increases expression		 ISO Hydralazine results in decreased methylation of DAPK1 promoter
Hydralazine results in increased expression of DAPK1 mRNA		 CTD PMID:15862127 NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991 		JBrowse link
G Dbf4b DBF4 zinc finger B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DBF4B mRNA CTD PMID:17183730 NCBI chr10:87,713,805...87,719,197 JBrowse link
G Dbi diazepam binding inhibitor, acyl-CoA binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DBI mRNA CTD PMID:17183730 NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693 		JBrowse link
G Dcaf8 DDB1 and CUL4 associated factor 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DCAF8 mRNA CTD PMID:17183730 NCBI chr13:84,609,838...84,667,025
Ensembl chr13:84,610,248...84,669,726 		JBrowse link
G Dclre1c DNA cross-link repair 1C multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DCLRE1C mRNA CTD PMID:17183730 NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186 		JBrowse link
G Dcp1a decapping mRNA 1A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DCP1A mRNA CTD PMID:17183730 NCBI chr16:5,656,788...5,702,151
Ensembl chr16:5,656,773...5,702,140 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of DDIT3 mRNA]; Hydralazine inhibits the reaction [Ethanol results in increased expression of DDIT3 protein] CTD PMID:28119953 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Ddt D-dopachrome tautomerase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDT mRNA CTD PMID:17183730 NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482 		JBrowse link
G Ddx27 DEAD-box helicase 27 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDX27 mRNA CTD PMID:17183730 NCBI chr 3:155,744,182...155,763,380
Ensembl chr 3:155,744,150...155,763,372 		JBrowse link
G Ddx46 DEAD-box helicase 46 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDX46 mRNA CTD PMID:17183730 NCBI chr17:8,944,197...8,988,476
Ensembl chr17:8,944,454...8,988,439 		JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of DLAT mRNA CTD PMID:17183730 NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479 		JBrowse link
G Dnaaf5 dynein, axonemal, assembly factor 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of DNAAF5 mRNA CTD PMID:17183730 NCBI chr12:15,453,636...15,492,722
Ensembl chr12:15,453,636...15,492,739 		JBrowse link
G Dnah14 dynein axonemal heavy chain 14 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAH14 mRNA CTD PMID:17183730 NCBI chr13:93,322,653...93,540,706 JBrowse link
G Dnaja3 DnaJ heat shock protein family (Hsp40) member A3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJA3 mRNA CTD PMID:17183730 NCBI chr10:10,855,510...10,880,175
Ensembl chr10:10,854,732...10,880,161 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJC3 mRNA CTD PMID:17183730 NCBI chr15:96,025,729...96,065,114
Ensembl chr15:96,025,624...96,065,181 		JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJC8 mRNA CTD PMID:17183730 NCBI chr 5:144,745,055...144,763,106
Ensembl chr 5:144,745,036...144,763,108 		JBrowse link
G Dnhd1 dynein heavy chain domain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNHD1 mRNA CTD PMID:17183730 NCBI chr 1:159,990,785...160,077,990
Ensembl chr 1:159,990,438...160,074,858 		JBrowse link
G Dpy19l3 dpy-19 like C-mannosyltransferase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DPY19L3 mRNA CTD PMID:17183730 NCBI chr 1:88,350,303...88,417,339
Ensembl chr 1:88,350,303...88,417,339 		JBrowse link
G Drd4 dopamine receptor D4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DRD4 mRNA CTD PMID:17183730 NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553 		JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DSCC1 mRNA CTD PMID:17183730 NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212 		JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DYNC1LI1 mRNA CTD PMID:17183730 NCBI chr 8:114,376,649...114,410,297
Ensembl chr 8:114,376,662...114,410,934 		JBrowse link
G Dynll1 dynein light chain LC8-type 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DYNLL1 mRNA CTD PMID:17183730 NCBI chr12:41,312,367...41,314,742
Ensembl chr12:41,312,367...41,314,741 		JBrowse link
G Edn1 endothelin 1 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of EDN1 mRNA] CTD PMID:16326922 NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Eef1d eukaryotic translation elongation factor 1 delta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EEF1D mRNA CTD PMID:17183730 NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799 		JBrowse link
G Efhb EF hand domain family, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EFHB mRNA CTD PMID:17183730 NCBI chr 9:6,372,191...6,441,678
Ensembl chr 9:6,372,194...6,441,919 		JBrowse link
G Efhd2 EF-hand domain family, member D2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EFHD2 mRNA CTD PMID:17183730 NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980 		JBrowse link
G Ehmt2 euchromatic histone lysine methyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA CTD PMID:17183730 NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547 		JBrowse link
G Eif3l eukaryotic translation initiation factor 3, subunit L multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EIF3L mRNA CTD PMID:17183730 NCBI chr 7:110,652,565...110,663,614
Ensembl chr 7:110,627,107...110,663,614 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EIF4B mRNA CTD PMID:17183730 NCBI chr 7:133,206,637...133,228,436 JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EIF4G3 mRNA CTD PMID:17183730 NCBI chr 5:150,197,410...150,418,363
Ensembl chr 5:150,195,226...150,418,363 		JBrowse link
G Elk3 ETS transcription factor ELK3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELK3 mRNA CTD PMID:17183730 NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084 		JBrowse link
G Ell elongation factor for RNA polymerase II multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELL mRNA CTD PMID:17183730 NCBI chr16:18,845,025...18,891,484
Ensembl chr16:18,843,780...18,891,118 		JBrowse link
G Ell3 elongation factor for RNA polymerase II 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ELL3 mRNA CTD PMID:17183730 NCBI chr 3:108,413,035...108,417,181
Ensembl chr 3:108,410,448...108,417,132 		JBrowse link
G Eln elastin multiple interactions EXP [Isoproterenol co-treated with Hydralazine] results in increased expression of ELN protein CTD PMID:3446201 NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928 		JBrowse link
G Elob elongin B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOB mRNA CTD PMID:17183730 NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOVL6 mRNA CTD PMID:17183730 NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186 		JBrowse link
G Emp3 epithelial membrane protein 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EMP3 mRNA CTD PMID:17183730 NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988 		JBrowse link
G Epas1 endothelial PAS domain protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPAS1 mRNA CTD PMID:17183730 NCBI chr 6:7,790,236...7,871,246
Ensembl chr 6:7,790,647...7,871,228 		JBrowse link
G Epc1 enhancer of polycomb homolog 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPC1 mRNA CTD PMID:17183730 NCBI chr17:54,503,358...54,594,444
Ensembl chr17:54,503,358...54,594,425 		JBrowse link
G Epha8 Eph receptor A8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPHA8 mRNA CTD PMID:17183730 NCBI chr 5:149,166,107...149,193,498
Ensembl chr 5:149,166,697...149,193,399 		JBrowse link
G Epn2 epsin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPN2 mRNA CTD PMID:17183730 NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642 		JBrowse link
G Eprs glutamyl-prolyl-tRNA synthetase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPRS1 mRNA CTD PMID:17183730 NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966 		JBrowse link
G Erlec1 endoplasmic reticulum lectin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ERLEC1 mRNA CTD PMID:17183730 NCBI chr14:104,655,745...104,693,508
Ensembl chr14:104,655,673...104,693,480 		JBrowse link
G Ero1b endoplasmic reticulum oxidoreductase 1 beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ERO1B mRNA CTD PMID:17183730 NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398 		JBrowse link
G Esr1 estrogen receptor 1 decreases methylation
multiple interactions
increases expression		 ISO Hydralazine results in decreased methylation of ESR1 promoter
Hydralazine inhibits the reaction [3-methylquinoline results in increased activity of ESR1 protein]; Hydralazine inhibits the reaction [8-methylquinoline results in increased activity of ESR1 protein]
Hydralazine results in increased expression of ESR1 mRNA		 CTD PMID:15862127 PMID:30896932 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Etl4 enhancer trap locus 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KIAA1217 mRNA CTD PMID:17183730 NCBI chr17:82,841,075...83,304,868
Ensembl chr17:82,495,041...83,304,715 		JBrowse link
G Exoc3l2 exocyst complex component 3-like 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EXOC3L2 mRNA CTD PMID:17183730 NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465 		JBrowse link
G Exoc7 exocyst complex component 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EXOC7 mRNA CTD PMID:17183730 NCBI chr10:101,521,640...101,563,123
Ensembl chr10:101,520,927...101,540,561 		JBrowse link
G F11r F11 receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of F11R mRNA CTD PMID:17183730 NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402 		JBrowse link
G F12 coagulation factor XII multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of F12 mRNA CTD PMID:17183730 NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530 		JBrowse link
G Fam120a family with sequence similarity 120A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM120A mRNA CTD PMID:17183730 NCBI chr17:15,684,233...15,774,964
Ensembl chr17:15,684,233...15,774,964 		JBrowse link
G Fam13b family with sequence similarity 13, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM13B mRNA CTD PMID:17183730 NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587 		JBrowse link
G Fam156b family with sequence similarity 156, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of TMEM29 mRNA CTD PMID:17183730 NCBI chr  X:19,338,236...19,340,924 JBrowse link
G Fam162a family with sequence similarity 162, member A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM162A mRNA CTD PMID:17183730 NCBI chr11:64,680,937...64,711,239
Ensembl chr11:64,680,323...64,711,239 		JBrowse link
G Fam163a family with sequence similarity 163, member A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of FAM163A mRNA CTD PMID:17183730 NCBI chr13:68,262,867...68,341,323
Ensembl chr13:68,262,872...68,341,049 		JBrowse link
G Fam210b family with sequence similarity 210, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM210B mRNA CTD PMID:17183730 NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397 		JBrowse link
G Fam241b family with sequence similarity 241 member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM241B mRNA CTD PMID:17183730 NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084 		JBrowse link
G Fam3a FAM3 metabolism regulating signaling molecule A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM3A mRNA CTD PMID:17183730 NCBI chr  X:152,166,716...152,175,327
Ensembl chr  X:152,165,535...152,175,362 		JBrowse link
G Fam50a family with sequence similarity 50, member A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM50A mRNA CTD PMID:17183730 NCBI chr  X:152,095,245...152,102,362
Ensembl chr  X:152,095,245...152,102,362 		JBrowse link
G Faslg Fas ligand multiple interactions ISO
EXP		 Hydralazine inhibits the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Acrolein results in increased expression of FASLG mRNA]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Zidovudine results in increased expression of FASLG mRNA]
Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Acrolein results in increased expression of FASLG mRNA]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine results in increased expression of FASLG mRNA]		 CTD PMID:27238871 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fbrsl1 fibrosin-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FBRSL1 mRNA CTD PMID:17183730 NCBI chr12:46,231,466...46,320,607
Ensembl chr12:46,231,495...46,320,357 		JBrowse link
G Fbxw4 F-box and WD repeat domain containing 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FBXW4 mRNA CTD PMID:17183730 NCBI chr 1:244,426,892...244,514,188
Ensembl chr 1:244,426,896...244,514,163 		JBrowse link
G Fdps farnesyl diphosphate synthase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FDPS mRNA CTD PMID:17183730 NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776 		JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FFAR3 mRNA CTD PMID:17183730 NCBI chr 1:86,105,388...86,106,728
Ensembl chr 1:86,104,920...86,106,849 		JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase decreases methylation
increases expression		 ISO Hydralazine results in decreased methylation of FHIT promoter
Hydralazine results in increased expression of FHIT mRNA		 CTD PMID:15862127 NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340 		JBrowse link
G Fis1 fission, mitochondrial 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FIS1 mRNA CTD PMID:17183730 NCBI chr12:19,708,558...19,723,392
Ensembl chr12:19,708,558...19,723,377 		JBrowse link
G Flot1 flotillin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FLOT1 mRNA CTD PMID:17183730 NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions EXP [Hydralazine co-treated with Hydrochlorothiazide] inhibits the reaction [Cyclosporine results in increased expression of FLT1 mRNA] CTD PMID:12110003 NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit affects expression EXP Hydralazine affects the expression of FOS protein CTD PMID:8750937 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Foxp1 forkhead box P1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FOXP1 mRNA CTD PMID:17183730 NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258 		JBrowse link
G Foxp2 forkhead box P2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of FOXP2 mRNA CTD PMID:17183730 NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683 		JBrowse link
G Foxp3 forkhead box P3 increases expression ISO Hydralazine results in increased expression of FOXP3 protein CTD PMID:19109157 NCBI chr  X:14,908,494...14,924,994
Ensembl chr  X:14,908,494...14,923,838 		JBrowse link
G Fst follistatin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FST mRNA CTD PMID:17183730 NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571 		JBrowse link
G Fstl5 follistatin-like 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FSTL5 mRNA CTD PMID:17183730 NCBI chr 2:160,857,989...161,526,589
Ensembl chr 2:160,856,291...161,526,589 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FTH1 mRNA CTD PMID:17183730 NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424 		JBrowse link
G Fthl17e ferritin, heavy polypeptide-like 17, member E multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FTHL17 mRNA CTD PMID:17183730 NCBI chr  X:49,595,422...49,596,399
Ensembl chr  X:49,595,718...49,596,266 		JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FXYD5 mRNA CTD PMID:17183730 NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519 		JBrowse link
G Gabarap GABA type A receptor-associated protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GABARAP mRNA CTD PMID:17183730 NCBI chr10:54,714,834...54,717,769
Ensembl chr10:54,714,198...54,717,765 		JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GALNT7 mRNA CTD PMID:17183730 NCBI chr16:32,578,643...32,703,189
Ensembl chr16:32,578,690...32,702,690 		JBrowse link
G Galp galanin-like peptide multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GALP mRNA CTD PMID:17183730 NCBI chr 1:67,684,023...67,703,121
Ensembl chr 1:67,684,025...67,702,269 		JBrowse link
G Gamt guanidinoacetate N-methyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GAMT mRNA CTD PMID:17183730 NCBI chr 7:9,448,590...9,451,778
Ensembl chr 7:9,448,628...9,451,778 		JBrowse link
G Ganab glucosidase II alpha subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GANAB mRNA CTD PMID:17183730 NCBI chr 1:205,793,810...205,813,701
Ensembl chr 1:205,793,895...205,813,695 		JBrowse link
G Gatd3a glutamine amidotransferase class 1 domain containing 3A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GATD3 mRNA CTD PMID:17183730 NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885 		JBrowse link
G Gfra2 GDNF family receptor alpha 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GFRA2 mRNA CTD PMID:17183730 NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714 		JBrowse link
G Gfra3 GDNF family receptor alpha 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GFRA3 mRNA CTD PMID:17183730 NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105 		JBrowse link
G Gjd4 gap junction protein, delta 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GJD4 mRNA CTD PMID:17183730 NCBI chr17:57,349,877...57,352,446
Ensembl chr17:57,349,877...57,352,446 		JBrowse link
G Gla galactosidase, alpha multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GLA mRNA CTD PMID:17183730 NCBI chr  X:97,769,227...97,780,646
Ensembl chr  X:97,768,996...97,780,664 		JBrowse link
G Gnpat glyceronephosphate O-acyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GNPAT mRNA CTD PMID:17183730 NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361 		JBrowse link
G Golgb1 golgin B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GOLGB1 mRNA CTD PMID:17183730 NCBI chr11:63,843,179...63,900,665
Ensembl chr11:63,843,986...63,900,770 		JBrowse link
G Golm2 golgi membrane protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GOLM2 mRNA CTD PMID:17183730 NCBI chr 3:108,827,017...108,896,207
Ensembl chr 3:108,827,047...108,896,207 		JBrowse link
G Gp2 glycoprotein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GP2 mRNA CTD PMID:17183730 NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619 		JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of GPAA1 mRNA CTD PMID:17183730 NCBI chr 7:108,051,896...108,055,479
Ensembl chr 7:108,051,861...108,055,484 		JBrowse link
G Gpbp1l1 GC-rich promoter binding protein 1-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GPBP1L1 mRNA CTD PMID:17183730 NCBI chr 5:130,009,773...130,050,636
Ensembl chr 5:130,023,137...130,050,459 		JBrowse link
G Gpr83 G protein-coupled receptor 83 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GPR83 mRNA CTD PMID:17183730 NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:11,693,540...11,704,028 		JBrowse link
G Gps2 G protein pathway suppressor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GPS2 mRNA CTD PMID:17183730 NCBI chr10:54,637,360...54,640,542
Ensembl chr10:54,637,455...54,640,650 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of GPT protein] CTD PMID:28119953 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Grap GRB2-related adaptor protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GRAP mRNA CTD PMID:17183730 NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056 		JBrowse link
G Grk3 G protein-coupled receptor kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of GRK3 mRNA CTD PMID:17183730 NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262 		JBrowse link
G Grk4 G protein-coupled receptor kinase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GRK4 mRNA CTD PMID:17183730 NCBI chr14:75,998,554...76,080,808
Ensembl chr14:76,006,218...76,080,693 		JBrowse link
G Grwd1 glutamate-rich WD repeat containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GRWD1 mRNA CTD PMID:17183730 NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201 		JBrowse link
G Gsn gelsolin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GSN mRNA CTD PMID:17183730 NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases methylation
increases expression		 ISO Hydralazine results in decreased methylation of GSTP1 promoter
Hydralazine results in increased expression of GSTP1 mRNA		 CTD PMID:15862127 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Gstt2 glutathione S-transferase, theta 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GSTT2 mRNA CTD PMID:17183730 NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288 		JBrowse link
G Guk1 guanylate kinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GUK1 mRNA CTD PMID:17183730 NCBI chr10:43,971,514...43,988,658
Ensembl chr10:43,971,509...43,980,107 		JBrowse link
G H3f3a H3.3 histone A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of H3-3A mRNA CTD PMID:17183730 NCBI chr13:92,533,294...92,544,903
Ensembl chr13:92,533,298...92,544,908 		JBrowse link
G Haao 3-hydroxyanthranilate 3,4-dioxygenase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HAAO mRNA CTD PMID:17183730 NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBA1 mRNA CTD PMID:17183730 NCBI chr10:15,323,830...15,324,677 JBrowse link
G Hbb hemoglobin subunit beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBB mRNA CTD PMID:17183730 NCBI chr 1:158,250,421...158,251,832 JBrowse link
G Hbz hemoglobin subunit zeta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBZ mRNA CTD PMID:17183730 NCBI chr10:15,343,821...15,345,301
Ensembl chr10:15,343,831...15,345,312 		JBrowse link
G Hcfc1r1 host cell factor C1 regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HCFC1R1 mRNA CTD PMID:17183730 NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850 		JBrowse link
G Hdgfl1 HDGF like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HDGFL1 mRNA CTD PMID:17183730 NCBI chr17:38,207,906...38,209,902 JBrowse link
G Heatr5b HEAT repeat containing 5B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HEATR5B mRNA CTD PMID:17183730 NCBI chr 6:16,243,424...16,323,439
Ensembl chr 6:16,243,461...16,323,435 		JBrowse link
G Hebp1 heme binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HEBP1 mRNA CTD PMID:17183730 NCBI chr 4:167,974,318...168,003,859
Ensembl chr 4:167,974,319...168,003,854 		JBrowse link
G Henmt1 HEN methyltransferase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HENMT1 mRNA CTD PMID:17183730 NCBI chr 2:196,585,732...196,603,700 JBrowse link
G Hfe homeostatic iron regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HFE mRNA CTD PMID:17183730 NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502 		JBrowse link
G Higd2a HIG1 hypoxia inducible domain family, member 2A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HIGD2A mRNA CTD PMID:17183730 NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796 		JBrowse link
G Hinfp histone H4 transcription factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HINFP mRNA CTD PMID:17183730 NCBI chr 8:44,634,333...44,644,288
Ensembl chr 8:44,634,333...44,641,000 		JBrowse link
G Hint1 histidine triad nucleotide binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HINT1 mRNA CTD PMID:17183730 NCBI chr10:38,989,516...38,993,259 JBrowse link
G Hint2 histidine triad nucleotide binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HINT2 mRNA CTD PMID:17183730 NCBI chr 5:57,904,613...57,906,868
Ensembl chr 5:57,904,614...57,907,097 		JBrowse link
G Hk1 hexokinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HK1 mRNA CTD PMID:17183730 NCBI chr20:30,230,488...30,332,161
Ensembl chr20:30,230,486...30,332,131 		JBrowse link
G Hmgcl 3-hydroxy-3-methylglutaryl-CoA lyase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HMGCL mRNA CTD PMID:17183730 NCBI chr 5:148,178,203...148,192,072
Ensembl chr 5:148,178,252...148,192,068 		JBrowse link
G Hmgxb4 HMG-box containing 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HMGXB4 mRNA CTD PMID:17183730 NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO Hydralazine inhibits the reaction [[Acrolein binds to ALB protein] which results in increased expression of HMOX1 mRNA] CTD PMID:32530271 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hps3 HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HPS3 mRNA CTD PMID:17183730 NCBI chr 2:102,484,574...102,527,580
Ensembl chr 2:102,484,574...102,526,047 		JBrowse link
G Hpse heparanase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HPSE mRNA CTD PMID:17183730 NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010 		JBrowse link
G Hsbp1 heat shock factor binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HSBP1 mRNA CTD PMID:17183730 NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of HSPA5 mRNA] CTD PMID:28119953 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HSPA8 mRNA CTD PMID:17183730 NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259 		JBrowse link
G Hyi hydroxypyruvate isomerase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HYI mRNA CTD PMID:17183730 NCBI chr 5:131,894,575...131,897,709
Ensembl chr 5:131,894,598...131,897,251 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ICAM1 mRNA CTD PMID:17183730 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438 		JBrowse link
G Icmt isoprenylcysteine carboxyl methyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ICMT mRNA CTD PMID:17183730 NCBI chr 5:162,804,368...162,811,129
Ensembl chr 5:162,804,368...162,811,128 		JBrowse link
G Idh3g isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IDH3G mRNA CTD PMID:17183730 NCBI chr  X:151,515,244...151,524,175
Ensembl chr  X:151,515,247...151,524,171 		JBrowse link
G Ifitm2 interferon induced transmembrane protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFITM2 mRNA CTD PMID:17183730 NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFRD1 mRNA CTD PMID:17183730 NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990 		JBrowse link
G Ift22 intraflagellar transport 22 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFT22 mRNA CTD PMID:17183730 NCBI chr12:19,759,072...19,768,859
Ensembl chr12:19,761,790...19,768,809 		JBrowse link
G Ift57 intraflagellar transport 57 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFT57 mRNA CTD PMID:17183730 NCBI chr11:51,051,520...51,124,909
Ensembl chr11:51,059,611...51,124,812 		JBrowse link
G Igbp1 immunoglobulin binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IGBP1 mRNA CTD PMID:17183730 NCBI chr  X:65,582,832...65,605,078
Ensembl chr  X:65,582,821...65,606,049 		JBrowse link
G Igf2bp2 insulin-like growth factor 2 mRNA binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IGF2BP2 mRNA CTD PMID:17183730 NCBI chr11:78,874,402...78,974,392
Ensembl chr11:78,874,414...78,974,377 		JBrowse link
G Il10 interleukin 10 increases secretion ISO Hydralazine results in increased secretion of IL10 protein CTD PMID:16612254 NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il1rapl2 interleukin 1 receptor accessory protein-like 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IL1RAPL2 mRNA CTD PMID:17183730 NCBI chr  X:100,961,509...102,271,753
Ensembl chr  X:100,961,812...102,271,753 		JBrowse link
G Il3 interleukin 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of IL3 mRNA CTD PMID:17183730 NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066 		JBrowse link
G Il6 interleukin 6 decreases secretion
increases expression		 ISO Hydralazine results in decreased secretion of IL6 protein
Hydralazine results in increased expression of IL6 protein		 CTD PMID:16612254 PMID:19575532 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Inava innate immunity activator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of INAVA mRNA CTD PMID:17183730 NCBI chr13:47,666,446...47,687,383
Ensembl chr13:47,666,447...47,686,729 		JBrowse link
G Ino80e INO80 complex subunit E multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of INO80E mRNA CTD PMID:17183730 NCBI chr 1:181,461,406...181,472,059
Ensembl chr 1:181,461,408...181,472,469 		JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IRF7 mRNA CTD PMID:17183730 NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832 		JBrowse link
G Irx3 iroquois homeobox 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IRX3 mRNA CTD PMID:17183730 NCBI chr19:15,211,882...15,215,323
Ensembl chr19:15,211,878...15,215,317 		JBrowse link
G Isca2 iron-sulfur cluster assembly 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ISCA2 mRNA CTD PMID:17183730 NCBI chr 6:104,418,509...104,420,019
Ensembl chr 6:104,418,454...104,420,045 		JBrowse link
G Itgam integrin subunit alpha M multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ITGAM mRNA CTD PMID:17183730 NCBI chr 1:182,659,047...182,709,495
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Itsn1 intersectin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ITSN1 mRNA CTD PMID:17183730 NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645 		JBrowse link
G Itsn2 intersectin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ITSN2 mRNA CTD PMID:17183730 NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124 		JBrowse link
G Jarid2 jumonji and AT-rich interaction domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of JARID2 mRNA CTD PMID:17183730 NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690 		JBrowse link
G Jmjd1c jumonji domain containing 1C multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of JMJD1C mRNA CTD PMID:17183730 NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122 		JBrowse link
G Kank1 KN motif and ankyrin repeat domains 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KANK1 mRNA CTD PMID:17183730 NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514 		JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KANK4 mRNA CTD PMID:17183730 NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555 		JBrowse link
G Kcna7 potassium voltage-gated channel subfamily A member 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of KCNA7 mRNA CTD PMID:17183730 NCBI chr 1:95,886,073...95,891,565
Ensembl chr 1:95,886,073...95,891,565 		JBrowse link
G Kdelr3 KDEL endoplasmic reticulum protein retention receptor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KDELR3 mRNA CTD PMID:17183730 NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600 		JBrowse link
G Klf6 Kruppel-like factor 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KLF6 mRNA CTD PMID:17183730 NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570 		JBrowse link
G Klhl9 kelch-like family member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KLHL9 mRNA CTD PMID:17183730 NCBI chr 5:103,333,747...103,337,931 JBrowse link
G Krt17 keratin 17 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of KRT17 mRNA CTD PMID:17183730 NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392 		JBrowse link
G Lasp1 LIM and SH3 protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LASP1 mRNA CTD PMID:17183730 NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292 		JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LEF1 mRNA CTD PMID:17183730 NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794 		JBrowse link
G Lgals1 galectin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS1 mRNA CTD PMID:17183730 NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345 		JBrowse link
G Lgals2 galectin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS2 mRNA CTD PMID:17183730 NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802 		JBrowse link
G Lgr4 leucine-rich repeat-containing G protein-coupled receptor 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LGR4 mRNA CTD PMID:17183730 NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899 		JBrowse link
G Lhfpl5 LHFPL tetraspan subfamily member 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LHFPL5 mRNA CTD PMID:17183730 NCBI chr20:6,632,362...6,642,534
Ensembl chr20:6,632,362...6,642,532 		JBrowse link
G Lin37 lin-37 DREAM MuvB core complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LIN37 mRNA CTD PMID:17183730 NCBI chr 1:85,809,065...85,813,235
Ensembl chr 1:85,809,074...85,812,991 		JBrowse link
G LOC102548695 zinc finger protein 45-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ZNF45 mRNA CTD PMID:17183730 NCBI chr 1:79,885,875...79,896,601
Ensembl chr 1:79,884,945...79,900,149 		JBrowse link
G LOC498675 hypothetical LOC498675 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C3ORF62 mRNA CTD PMID:17183730 NCBI chr 8:109,080,032...109,084,650
Ensembl chr 8:109,036,030...109,097,895 		JBrowse link
G LOC685849 hypothetical protein LOC685849 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C9ORF152 mRNA CTD PMID:17183730 NCBI chr 5:72,660,573...72,669,438
Ensembl chr 5:72,660,573...72,668,379 		JBrowse link
G LOC686596 similar to aquaporin 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AQP10 mRNA CTD PMID:17183730 NCBI chr 2:175,402,609...175,407,677
Ensembl chr 2:175,403,263...175,406,815 		JBrowse link
G LOC690035 similar to Protein KIAA0586 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KIAA0586 mRNA CTD PMID:17183730 NCBI chr 6:89,622,711...89,725,951
Ensembl chr 6:89,623,699...89,725,962 		JBrowse link
G Lpcat4 lysophosphatidylcholine acyltransferase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPCAT4 mRNA CTD PMID:17183730 NCBI chr 3:99,044,729...99,052,963
Ensembl chr 3:99,044,729...99,052,875 		JBrowse link
G Lpgat1 lysophosphatidylglycerol acyltransferase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPGAT1 mRNA CTD PMID:17183730 NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333 		JBrowse link
G Lpin3 lipin 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPIN3 mRNA CTD PMID:17183730 NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327 		JBrowse link
G Lpp LIM domain containing preferred translocation partner in lipoma multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPP mRNA CTD PMID:17183730 NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597 		JBrowse link
G Lrfn1 leucine rich repeat and fibronectin type III domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRFN1 mRNA CTD PMID:17183730 NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449 		JBrowse link
G Lrp10 LDL receptor related protein 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRP10 mRNA CTD PMID:17183730 NCBI chr15:27,921,105...27,927,507
Ensembl chr15:27,920,259...27,927,505 		JBrowse link
G Lrrc40 leucine rich repeat containing 40 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRRC40 mRNA CTD PMID:17183730 NCBI chr 2:247,101,484...247,131,061
Ensembl chr 2:247,101,500...247,131,059 		JBrowse link
G Lrrc8e leucine rich repeat containing 8 VRAC subunit E multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRRC8E mRNA CTD PMID:17183730 NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412 		JBrowse link
G Luc7l3 LUC7-like 3 pre-mRNA splicing factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CROP mRNA CTD PMID:17183730 NCBI chr10:79,240,050...79,276,555
Ensembl chr10:79,240,563...79,276,538 		JBrowse link
G Ly86 lymphocyte antigen 86 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LY86 mRNA CTD PMID:17183730 NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260 		JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MAOA mRNA CTD PMID:17183730 NCBI chr  X:6,032,172...6,098,308
Ensembl chr  X:6,030,795...6,099,593 		JBrowse link
G Map2k3 mitogen activated protein kinase kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MAP2K3 mRNA CTD PMID:17183730 NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions EXP Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK1 protein] CTD PMID:16344371 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions EXP Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK3 protein] CTD PMID:16344371 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mark3 microtubule affinity regulating kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MARK3 mRNA CTD PMID:17183730 NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647 		JBrowse link
G Mas1 MAS1 proto-oncogene, G protein-coupled receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MAS1 mRNA CTD PMID:17183730 NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709 		JBrowse link
G Mbd6 methyl-CpG binding domain protein 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MBD6 mRNA CTD PMID:17183730 NCBI chr 7:63,107,562...63,115,841
Ensembl chr 7:63,107,562...63,113,274 		JBrowse link
G Mboat7 membrane bound O-acyltransferase domain containing 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MBOAT7 mRNA CTD PMID:17183730 NCBI chr 1:65,525,206...65,539,538 JBrowse link
G Me2 malic enzyme 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ME2 mRNA CTD PMID:17183730 NCBI chr18:67,350,833...67,400,987
Ensembl chr18:67,355,795...67,400,987 		JBrowse link
G Mettl3 methyltransferase-like 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of METTL3 mRNA CTD PMID:17183730 NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041 		JBrowse link
G Mettl6 methyltransferase like 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of METTL6 mRNA CTD PMID:17183730 NCBI chr16:6,683,820...6,699,013 JBrowse link
G Mfsd5 major facilitator superfamily domain containing 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MFSD5 mRNA CTD PMID:17183730 NCBI chr 7:133,409,096...133,411,377
Ensembl chr 7:133,402,537...133,411,396 		JBrowse link
G Mgat1 alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MGAT1 mRNA CTD PMID:17183730 NCBI chr10:33,563,642...33,582,718
Ensembl chr10:33,561,388...33,591,503 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase decreases methylation
increases expression		 ISO Hydralazine results in decreased methylation of MGMT promoter
Hydralazine results in increased expression of MGMT mRNA		 CTD PMID:15862127 NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756 		JBrowse link
G Mgp matrix Gla protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MGP mRNA CTD PMID:17183730 NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667 		JBrowse link
G Mical3 microtubule associated monooxygenase, calponin and LIM domain containing 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MICAL3 mRNA CTD PMID:17183730 NCBI chr 4:154,152,776...154,353,274
Ensembl chr 4:154,153,834...154,302,590 		JBrowse link
G Micos13 mitochondrial contact site and cristae organizing system subunit 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MICOS13 mRNA CTD PMID:17183730 NCBI chr 9:1,439,058...1,442,092
Ensembl chr 9:1,439,058...1,442,076 		JBrowse link
G Mis12 MIS12 kinetochore complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MIS12 mRNA CTD PMID:17183730 NCBI chr10:55,739,590...55,747,915
Ensembl chr10:55,739,564...55,751,068 		JBrowse link
G Mks1 MKS transition zone complex subunit 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MKS1 mRNA CTD PMID:17183730 NCBI chr10:72,655,921...72,667,007
Ensembl chr10:72,655,921...72,666,655 		JBrowse link
G Mllt10 MLLT10, histone lysine methyltransferase DOT1L cofactor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MLLT10 mRNA CTD PMID:17183730 NCBI chr17:80,821,870...80,949,349
Ensembl chr17:80,822,556...80,949,345 		JBrowse link
G Mmab metabolism of cobalamin associated B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MMAB mRNA CTD PMID:17183730 NCBI chr12:42,159,109...42,172,496
Ensembl chr12:42,159,089...42,172,490 		JBrowse link
G Mme membrane metallo-endopeptidase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MME mRNA CTD PMID:17183730 NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792 		JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MMP10 mRNA CTD PMID:17183730 NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748 		JBrowse link
G Mmp25 matrix metallopeptidase 25 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MMP25 mRNA CTD PMID:17183730 NCBI chr10:12,661,297...12,676,119 JBrowse link
G Mpst mercaptopyruvate sulfurtransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MPST mRNA CTD PMID:17183730 NCBI chr 7:109,955,581...109,963,155
Ensembl chr 7:109,955,675...109,963,141 		JBrowse link
G Mrnip MRN complex interacting protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRNIP mRNA CTD PMID:17183730 NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469 		JBrowse link
G mrpl11 mitochondrial ribosomal protein L11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL11 mRNA CTD PMID:17183730 NCBI chr 1:202,264,419...202,267,288
Ensembl chr 1:202,264,471...202,267,756 		JBrowse link
G Mrpl39 mitochondrial ribosomal protein L39 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL39 mRNA CTD PMID:17183730 NCBI chr11:23,779,655...23,795,146
Ensembl chr11:23,779,662...23,795,125 		JBrowse link
G Mrpl45 mitochondrial ribosomal protein L45 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL45 mRNA CTD PMID:17183730 NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474 		JBrowse link
G Mrpl53 mitochondrial ribosomal protein L53 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL53 mRNA CTD PMID:17183730 NCBI chr 4:115,615,329...115,616,219 JBrowse link
G Mrps12 mitochondrial ribosomal protein S12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS12 mRNA CTD PMID:17183730 NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780 		JBrowse link
G Mrps18a mitochondrial ribosomal protein S18A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS18A mRNA CTD PMID:17183730 NCBI chr 9:14,853,322...14,869,819
Ensembl chr 9:14,853,291...14,869,835 		JBrowse link
G Mrps24 mitochondrial ribosomal protein S24 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS24 mRNA CTD PMID:17183730 NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871 		JBrowse link
G Mrps5 mitochondrial ribosomal protein S5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS5 mRNA CTD PMID:17183730 NCBI chr 3:114,821,046...114,837,291
Ensembl chr 3:114,821,046...114,837,291 		JBrowse link
G Mrrf mitochondrial ribosome recycling factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRRF mRNA CTD PMID:17183730 NCBI chr 3:19,487,124...19,543,911
Ensembl chr 3:19,487,182...19,543,908 		JBrowse link
G Mta3 metastasis associated 1 family, member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MTA3 mRNA CTD PMID:17183730 NCBI chr 6:10,867,028...10,987,221
Ensembl chr 6:10,867,011...10,986,883 		JBrowse link
G Mtmr4 myotubularin related protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MTMR4 mRNA CTD PMID:17183730 NCBI chr10:72,393,411...72,416,342
Ensembl chr10:72,392,551...72,416,342 		JBrowse link
G Muc1 mucin 1, cell surface associated multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MUC1 mRNA CTD PMID:17183730 NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733 		JBrowse link
G Mybl2 MYB proto-oncogene like 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYBL2 mRNA CTD PMID:17183730 NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708 		JBrowse link
G Mycbp2 MYC binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYCBP2 mRNA CTD PMID:17183730 NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498 		JBrowse link
G Myh7 myosin heavy chain 7 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of MYH7 mRNA] CTD PMID:16326922 NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217 		JBrowse link
G Myl6b myosin light chain 6B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYL6B mRNA CTD PMID:17183730 NCBI chr  X:40,572,012...40,572,991 JBrowse link
G Myom1 myomesin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYOM1 mRNA CTD PMID:17183730 NCBI chr 9:110,916,156...111,039,344
Ensembl chr 9:110,915,943...111,039,344 		JBrowse link
G Myot myotilin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYOT mRNA CTD PMID:17183730 NCBI chr18:36,705,244...36,724,849
Ensembl chr18:36,705,314...36,724,841 		JBrowse link
G Naa10 N(alpha)-acetyltransferase 10, NatA catalytic subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NAA10 mRNA CTD PMID:17183730 NCBI chr  X:151,656,056...151,661,304
Ensembl chr  X:151,656,056...151,661,252 		JBrowse link
G Naa38 N(alpha)-acetyltransferase 38, NatC auxiliary subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NAA38 mRNA CTD PMID:17183730 NCBI chr10:54,117,754...54,118,913
Ensembl chr10:54,117,163...54,119,494 		JBrowse link
G Nalcn sodium leak channel, non-selective multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NALCN mRNA CTD PMID:17183730 NCBI chr15:100,398,615...100,712,283
Ensembl chr15:100,398,615...100,741,001 		JBrowse link
G Nalf2 NALCN channel auxiliary factor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NALF2 mRNA CTD PMID:17183730 NCBI chr  X:64,925,100...64,951,074
Ensembl chr  X:64,925,051...64,951,077 		JBrowse link
G Nampt nicotinamide phosphoribosyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NAMPT mRNA CTD PMID:17183730 NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100 		JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NAP1L1 mRNA CTD PMID:17183730 NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593 		JBrowse link
G Nat2 N-acetyltransferase 2 increases acetylation
affects metabolic processing		 ISO NAT2 protein results in increased acetylation of Hydralazine
NAT2 protein affects the metabolism of Hydralazine		 CTD PMID:15627487 NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520 		JBrowse link
G Nbeal1 neurobeachin-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NBEAL1 mRNA CTD PMID:17183730 NCBI chr 9:61,575,154...61,743,896
Ensembl chr 9:61,575,356...61,736,750 		JBrowse link
G Nbr1 NBR1, autophagy cargo receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NBR1 mRNA CTD PMID:17183730 NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,478,290...86,506,412 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NCF1 mRNA CTD PMID:17183730 NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646 		JBrowse link
G Ncoa4 nuclear receptor coactivator 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NCOA4 mRNA CTD PMID:17183730 NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641
Ensembl chr16:7,366,542...7,409,641 		JBrowse link
G Ncor1 nuclear receptor co-repressor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NCOR1 mRNA CTD PMID:17183730 NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032 		JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NCR1 mRNA CTD PMID:17183730 NCBI chr 1:69,614,744...69,622,570 JBrowse link
G Ndufa1 NADH:ubiquinone oxidoreductase subunit A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA1 mRNA CTD PMID:17183730 NCBI chr  X:116,424,223...116,427,875
Ensembl chr  X:116,424,223...116,428,633 		JBrowse link
G Ndufa13 NADH:ubiquinone oxidoreductase subunit A13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA13 mRNA CTD PMID:17183730 NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726 		JBrowse link
G Ndufa3 NADH:ubiquinone oxidoreductase subunit A3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA3 mRNA CTD PMID:17183730 NCBI chr 1:65,597,562...65,600,242
Ensembl chr 1:65,597,578...65,600,235 		JBrowse link
G Ndufa5 NADH:ubiquinone oxidoreductase subunit A5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA5 mRNA CTD PMID:17183730 NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598 		JBrowse link
G Ndufa6 NADH:ubiquinone oxidoreductase subunit A6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA6 mRNA CTD PMID:17183730 NCBI chr 7:113,866,382...113,870,239
Ensembl chr 7:113,866,382...113,870,239 		JBrowse link
G Ndufaf6 NADH:ubiquinone oxidoreductase complex assembly factor 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFAF6 mRNA CTD PMID:17183730 NCBI chr 5:24,147,712...24,171,981
Ensembl chr 5:24,147,735...24,171,951 		JBrowse link
G Ndufb1 NADH:ubiquinone oxidoreductase subunit B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFB1 mRNA CTD PMID:17183730 NCBI chr 6:121,115,649...121,124,056 JBrowse link
G Ndufb10 NADH:ubiquinone oxidoreductase subunit B10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFB10 mRNA CTD PMID:17183730 NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442 		JBrowse link
G Ndufb2 NADH:ubiquinone oxidoreductase subunit B2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFB2 mRNA CTD PMID:17183730 NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 		JBrowse link
G Ndufs5 NADH:ubiquinone oxidoreductase subunit S5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFS5 mRNA CTD PMID:17183730 NCBI chr 5:135,974,029...135,979,705
Ensembl chr 5:135,974,034...135,979,603 		JBrowse link
G Nedd1 NEDD1 gamma-tubulin ring complex targeting factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NEDD1 mRNA CTD PMID:17183730 NCBI chr 7:27,233,315...27,274,486
Ensembl chr 7:27,233,316...27,274,486 		JBrowse link
G Net1 neuroepithelial cell transforming 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NET1 mRNA CTD PMID:17183730 NCBI chr17:66,341,251...66,370,445
Ensembl chr17:66,340,728...66,370,441 		JBrowse link
G Nf1 neurofibromin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NF1 mRNA CTD PMID:17183730 NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658 		JBrowse link
G Nfatc2 nuclear factor of activated T-cells 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NFATC2 mRNA CTD PMID:17183730 NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325 		JBrowse link
G Nhlrc2 NHL repeat containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NHLRC2 mRNA CTD PMID:17183730 NCBI chr 1:255,589,742...255,650,448
Ensembl chr 1:255,589,742...255,651,408 		JBrowse link
G Nhs NHS actin remodeling regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NHS mRNA CTD PMID:17183730 NCBI chr  X:32,551,974...32,892,961
Ensembl chr  X:32,552,026...32,889,992 		JBrowse link
G Nmd3 NMD3 ribosome export adaptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NMD3 mRNA CTD PMID:17183730 NCBI chr 2:154,012,973...154,038,466
Ensembl chr 2:154,013,020...154,039,259 		JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NME1 mRNA CTD PMID:17183730 NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408 		JBrowse link
G Nod1 nucleotide-binding oligomerization domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NOD1 mRNA CTD PMID:17183730 NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404 		JBrowse link
G Nos1 nitric oxide synthase 1 increases expression EXP Hydralazine results in increased expression of NOS1 mRNA CTD PMID:7533141 NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945 		JBrowse link
G Nova1 NOVA alternative splicing regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NOVA1 mRNA CTD PMID:17183730 NCBI chr 6:63,780,105...63,905,950
Ensembl chr 6:63,783,489...63,906,289 		JBrowse link
G Npas3 neuronal PAS domain protein 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPAS3 mRNA CTD PMID:17183730 NCBI chr 6:70,702,773...71,527,928 JBrowse link
G Npdc1 neural proliferation, differentiation and control, 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPDC1 mRNA CTD PMID:17183730 NCBI chr 3:8,220,446...8,226,446 JBrowse link
G Nphp4 nephrocystin 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPHP4 mRNA CTD PMID:17183730 NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706 		JBrowse link
G Nppb natriuretic peptide B multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA] CTD PMID:16326922 NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168 		JBrowse link
G Npr1 natriuretic peptide receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPR1 mRNA CTD PMID:17183730 NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505 		JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NR1H3 mRNA CTD PMID:17183730 NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722 		JBrowse link
G Nr2c2 nuclear receptor subfamily 2, group C, member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NR2C2 mRNA CTD PMID:17183730 NCBI chr 4:124,610,216...124,666,813
Ensembl chr 4:124,608,960...124,661,902 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NR3C1 mRNA CTD PMID:17183730 NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375 		JBrowse link
G Nrep neuronal regeneration related protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NREP mRNA CTD PMID:17183730 NCBI chr18:25,017,069...25,046,564
Ensembl chr18:25,017,083...25,046,591 		JBrowse link
G Nrxn2 neurexin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NRXN2 mRNA CTD PMID:17183730 NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297 		JBrowse link
G Nsdhl NAD(P) dependent steroid dehydrogenase-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NSDHL mRNA CTD PMID:17183730 NCBI chr  X:150,775,034...150,807,161
Ensembl chr  X:150,775,080...150,807,142 		JBrowse link
G Nsfl1c NSFL1 cofactor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NSFL1C mRNA CTD PMID:17183730 NCBI chr 3:139,978,306...140,002,876
Ensembl chr 3:139,978,301...140,002,870 		JBrowse link
G Nsun4 NOP2/Sun RNA methyltransferase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NSUN4 mRNA CTD PMID:17183730 NCBI chr 5:129,511,224...129,532,498
Ensembl chr 5:129,512,307...129,532,423
Ensembl chr 5:129,512,307...129,532,423 		JBrowse link
G Ntan1 N-terminal asparagine amidase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NTAN1 mRNA CTD PMID:17183730 NCBI chr10:2,111,085...2,126,123 JBrowse link
G Ntsr2 neurotensin receptor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NTSR2 mRNA CTD PMID:17183730 NCBI chr 6:39,424,297...39,431,015
Ensembl chr 6:39,424,324...39,431,014 		JBrowse link
G Nudc nuclear distribution C, dynein complex regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUDC mRNA CTD PMID:17183730 NCBI chr 5:145,758,006...145,771,390
Ensembl chr 5:145,758,002...145,771,425 		JBrowse link
G Nudt7 nudix hydrolase 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NUDT7 mRNA CTD PMID:17183730 NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081 		JBrowse link
G Numb NUMB, endocytic adaptor protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUMB mRNA CTD PMID:17183730 NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354 		JBrowse link
G Nup153 nucleoporin 153 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUP153 mRNA CTD PMID:17183730 NCBI chr17:17,972,217...18,024,876
Ensembl chr17:17,972,217...18,024,876 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUPR1 mRNA CTD PMID:17183730 NCBI chr 1:181,213,292...181,215,327 JBrowse link
G Nxph3 neurexophilin 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NXPH3 mRNA CTD PMID:17183730 NCBI chr10:80,456,283...80,459,949
Ensembl chr10:80,455,429...80,462,415 		JBrowse link
G Oaz1 ornithine decarboxylase antizyme 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OAZ1 mRNA CTD PMID:17183730 NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310 		JBrowse link
G Obscn obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OBSCN mRNA CTD PMID:17183730 NCBI chr10:43,774,113...43,919,718
Ensembl chr10:43,789,293...43,919,723 		JBrowse link
G Ociad2 OCIA domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OCIAD2 mRNA CTD PMID:17183730 NCBI chr14:34,873,668...34,889,276
Ensembl chr14:34,873,820...34,889,265 		JBrowse link
G Ofcc1 orofacial cleft 1 candidate 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of OFCC1 mRNA CTD PMID:17183730 NCBI chr17:24,506,919...24,813,225
Ensembl chr17:24,539,047...24,811,079 		JBrowse link
G Oga O-GlcNAcase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OGA mRNA CTD PMID:17183730 NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359 		JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OGG1 mRNA CTD PMID:17183730 NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OGT mRNA CTD PMID:17183730 NCBI chr  X:66,771,278...66,816,148
Ensembl chr  X:66,771,349...66,816,146 		JBrowse link
G Olr384 olfactory receptor 384 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OR9I1 mRNA CTD PMID:17183730 NCBI chr 1:211,096,191...211,097,141
Ensembl chr 1:211,090,402...211,097,815 		JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OPA1 mRNA CTD PMID:17183730 NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109 		JBrowse link
G Oprd1 opioid receptor, delta 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of OPRD1 mRNA CTD PMID:17183730 NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960 		JBrowse link
G P2rx3 purinergic receptor P2X 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of P2RX3 mRNA CTD PMID:17183730 NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178 		JBrowse link
G Pafah1b3 platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PAFAH1B3 mRNA CTD PMID:17183730 NCBI chr 1:80,881,263...80,883,789
Ensembl chr 1:80,881,309...80,883,893 		JBrowse link
G Park7 Parkinsonism associated deglycase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PARK7 mRNA CTD PMID:17183730 NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP1 mRNA CTD PMID:17183730 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Parp14 poly (ADP-ribose) polymerase family, member 14 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP14 mRNA CTD PMID:17183730 NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916 		JBrowse link
G Pasd1 PAS domain containing repressor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PASD1 mRNA CTD PMID:17183730 NCBI chr  X:149,617,933...149,639,214
Ensembl chr  X:149,620,972...149,638,675 		JBrowse link
G Pbx2 PBX homeobox 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PBX2 mRNA CTD PMID:17183730 NCBI chr20:4,151,500...4,156,425
Ensembl chr20:4,151,500...4,156,425 		JBrowse link
G Pcbd1 pterin-4 alpha-carbinolamine dehydratase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PCBD1 mRNA CTD PMID:17183730 NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292
Ensembl chr20:28,953,864...29,044,292 		JBrowse link
G Pccb propionyl-CoA carboxylase subunit beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PCCB mRNA CTD PMID:17183730 NCBI chr 8:101,591,218...101,641,213
Ensembl chr 8:101,590,737...101,641,234 		JBrowse link
G Pcdh15 protocadherin related 15 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PCDH15 mRNA CTD PMID:17183730 NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein CTD PMID:11318962 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
G Pebp4 phosphatidylethanolamine binding protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PEBP4 mRNA CTD PMID:17183730 NCBI chr15:44,920,946...45,134,188 JBrowse link
G Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PFKFB4 mRNA CTD PMID:17183730 NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634 		JBrowse link
G Pfn1 profilin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PFN1 mRNA CTD PMID:17183730 NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631 		JBrowse link
G Pgam2 phosphoglycerate mutase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PGAM2 mRNA CTD PMID:17183730 NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940 		JBrowse link
G Pgm1 phosphoglucomutase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PGM1 mRNA CTD PMID:17183730 NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728 		JBrowse link
G Phb1 prohibitin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PHB mRNA CTD PMID:17183730 NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042 		JBrowse link
G Phc1 polyhomeotic homolog 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of PHC1 mRNA CTD PMID:17183730 NCBI chr 4:155,510,274...155,532,636
Ensembl chr 4:155,510,274...155,533,959 		JBrowse link
G Phc2 polyhomeotic homolog 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PHC2 mRNA CTD PMID:17183730 NCBI chr 5:141,000,604...141,099,268
Ensembl chr 5:141,050,842...141,099,268 		JBrowse link
G Phf24 PHD finger protein 24 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PHF24 mRNA CTD PMID:17183730 NCBI chr 5:57,143,428...57,171,054
Ensembl chr 5:57,142,632...57,168,497 		JBrowse link
G Pigs phosphatidylinositol glycan anchor biosynthesis, class S multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PIGS mRNA CTD PMID:17183730 NCBI chr10:63,222,611...63,237,190
Ensembl chr10:63,222,572...63,237,187 		JBrowse link
G Pip prolactin induced protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PIP mRNA CTD PMID:17183730 NCBI chr 4:70,787,627...70,791,921
Ensembl chr 4:70,787,627...70,791,921 		JBrowse link
G Plcg1 phospholipase C, gamma 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PLCG1 mRNA CTD PMID:17183730 NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330 		JBrowse link
G Plrg1 pleiotropic regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PLRG1 mRNA CTD PMID:17183730 NCBI chr 2:168,408,139...168,424,470
Ensembl chr 2:168,408,124...168,424,522 		JBrowse link
G Plxdc1 plexin domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PLXDC1 mRNA CTD PMID:17183730 NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130 		JBrowse link
G Pmm2 phosphomannomutase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PMM2 mRNA CTD PMID:17183730 NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098 		JBrowse link
G Pmvk phosphomevalonate kinase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PMVK mRNA CTD PMID:17183730 NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364 		JBrowse link
G Pole4 DNA polymerase epsilon 4, accessory subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of POLE4 mRNA CTD PMID:17183730 NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097 		JBrowse link
G Polr2l RNA polymerase II, I and III subunit L multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of POLR2L mRNA CTD PMID:17183730 NCBI chr 1:196,570,051...196,572,060 JBrowse link
G Pop5 POP5 homolog, ribonuclease P/MRP subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of POP5 mRNA CTD PMID:17183730 NCBI chr12:41,376,755...41,384,882
Ensembl chr12:41,376,755...41,381,336 		JBrowse link
G Ppil4 peptidylprolyl isomerase like 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPIL4 mRNA CTD PMID:17183730 NCBI chr 1:2,273,582...2,306,212
Ensembl chr 1:2,273,609...2,305,632 		JBrowse link
G Ppp1r12a protein phosphatase 1, regulatory subunit 12A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP1R12A mRNA CTD PMID:17183730 NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425 		JBrowse link
G Ppp1r9a protein phosphatase 1, regulatory subunit 9A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP1R9A mRNA CTD PMID:17183730 NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907 		JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP2R1B mRNA CTD PMID:17183730 NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485 		JBrowse link
G Prb3 proline-rich protein BstNI subfamily 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRB3 mRNA CTD PMID:17183730 NCBI chr 4:165,564,424...165,569,229
Ensembl chr 4:165,564,424...165,569,227 		JBrowse link
G Prkcsh protein kinase C substrate 80K-H multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRKCSH mRNA CTD PMID:17183730 NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492 		JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRKG1 mRNA CTD PMID:17183730 NCBI chr 1:228,409,883...229,638,794 JBrowse link
G Prom2 prominin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PROM2 mRNA CTD PMID:17183730 NCBI chr 3:114,747,654...114,761,787
Ensembl chr 3:114,747,654...114,761,787 		JBrowse link
G Prpf18 pre-mRNA processing factor 18 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRPF18 mRNA CTD PMID:17183730 NCBI chr17:73,630,560...73,661,210
Ensembl chr17:73,630,571...73,690,979 		JBrowse link
G Prr13 proline rich 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRR13 mRNA CTD PMID:17183730 NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005 		JBrowse link
G Prtfdc1 phosphoribosyl transferase domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRTFDC1 mRNA CTD PMID:17183730 NCBI chr17:83,548,792...83,654,852
Ensembl chr17:83,548,803...83,655,179 		JBrowse link
G Psd3 pleckstrin and Sec7 domain containing 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSD3 mRNA CTD PMID:17183730 NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547 		JBrowse link
G Psma2 proteasome 20S subunit alpha 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMA2 mRNA CTD PMID:17183730 NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938 		JBrowse link
G Psma4 proteasome 20S subunit alpha 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMA4 mRNA CTD PMID:17183730 NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:55,340,386...55,347,890 		JBrowse link
G Psmb1 proteasome 20S subunit beta 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB1 mRNA CTD PMID:17183730 NCBI chr 1:56,442,432...56,463,544
Ensembl chr 1:56,420,618...56,463,560 		JBrowse link
G Psmb2 proteasome 20S subunit beta 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB2 mRNA CTD PMID:17183730 NCBI chr 5:138,970,564...139,002,715
Ensembl chr 5:138,970,533...139,021,137 		JBrowse link
G Psmb3 proteasome 20S subunit beta 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB3 mRNA CTD PMID:17183730 NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521 		JBrowse link
G Psmb6 proteasome 20S subunit beta 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB6 mRNA CTD PMID:17183730 NCBI chr10:55,239,274...55,241,581
Ensembl chr10:55,239,241...55,241,586 		JBrowse link
G Psmb9 proteasome 20S subunit beta 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB9 mRNA CTD PMID:17183730 NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512 		JBrowse link
G Psmc6 proteasome 26S subunit, ATPase 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMC6 mRNA CTD PMID:17183730 NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055 		JBrowse link
G Psmd1 proteasome 26S subunit, non-ATPase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMD1 mRNA CTD PMID:17183730 NCBI chr 9:86,709,714...86,785,213
Ensembl chr 9:86,709,947...86,785,211 		JBrowse link
G Psmd3 proteasome 26S subunit, non-ATPase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of PSMD3 mRNA CTD PMID:17183730 NCBI chr10:83,643,473...83,655,620
Ensembl chr10:83,643,647...83,655,618 		JBrowse link
G Psmd4 proteasome 26S subunit ubiquitin receptor, non-ATPase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMD4 mRNA CTD PMID:17183730 NCBI chr 2:182,598,934...182,608,250
Ensembl chr 2:182,598,934...182,608,194 		JBrowse link
G Psmd8 proteasome 26S subunit, non-ATPase 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMD8 mRNA CTD PMID:17183730 NCBI chr 1:84,474,377...84,481,209
Ensembl chr 1:84,474,378...84,481,209 		JBrowse link
G Psmg3 proteasome assembly chaperone 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMG3 mRNA CTD PMID:17183730 NCBI chr12:14,809,234...14,812,347
Ensembl chr12:14,809,450...14,812,342 		JBrowse link
G Ptk2b protein tyrosine kinase 2 beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PTK2B mRNA CTD PMID:17183730 NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282 		JBrowse link
G Ptma prothymosin alpha multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PTMA mRNA CTD PMID:17183730 NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333 		JBrowse link
G Ptprj protein tyrosine phosphatase, receptor type, J multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PTPRJ mRNA CTD PMID:17183730 NCBI chr 3:76,405,917...76,561,842
Ensembl chr 3:76,405,927...76,562,260 		JBrowse link
G Puf60 poly-U binding splicing factor 60 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PUF60 mRNA CTD PMID:17183730 NCBI chr 7:107,782,770...107,793,814
Ensembl chr 7:107,782,770...107,794,531 		JBrowse link
G Pum1 pumilio RNA-binding family member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PUM1 mRNA CTD PMID:17183730 NCBI chr 5:142,836,933...142,954,331
Ensembl chr 5:142,837,127...142,954,039 		JBrowse link
G Pycard PYD and CARD domain containing multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PYCARD mRNA CTD PMID:17183730 NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955 		JBrowse link
G Pycr3 pyrroline-5-carboxylate reductase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PYCR3 mRNA CTD PMID:17183730 NCBI chr 7:107,603,543...107,608,831 JBrowse link
G Rab13 RAB13, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB13 mRNA CTD PMID:17183730 NCBI chr 2:175,674,894...175,680,043
Ensembl chr 2:175,675,005...175,680,036 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB1A mRNA CTD PMID:17183730 NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248 		JBrowse link
G Rab30 RAB30, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB30 mRNA CTD PMID:17183730 NCBI chr 1:146,803,652...146,898,369
Ensembl chr 1:146,803,714...146,892,181 		JBrowse link
G Rab3a RAB3A, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB3A mRNA CTD PMID:17183730 NCBI chr16:18,684,185...18,688,297
Ensembl chr16:18,684,188...18,688,336 		JBrowse link
G Rab3d RAB3D, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB3D mRNA CTD PMID:17183730 NCBI chr 8:20,438,622...20,449,269
Ensembl chr 8:20,439,294...20,449,185 		JBrowse link
G Rab6a RAB6A, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB6A mRNA CTD PMID:17183730 NCBI chr 1:154,957,870...155,008,922
Ensembl chr 1:154,958,189...154,996,715 		JBrowse link
G Rabep2 rabaptin, RAB GTPase binding effector protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RABEP2 mRNA CTD PMID:17183730 NCBI chr 1:181,010,305...181,026,651
Ensembl chr 1:181,010,305...181,026,648 		JBrowse link
G Rabgef1 RAB guanine nucleotide exchange factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RABGEF1 mRNA CTD PMID:17183730 NCBI chr12:26,459,190...26,503,790
Ensembl chr12:26,460,175...26,503,744 		JBrowse link
G Rad21 RAD21 cohesin complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAD21 mRNA CTD PMID:17183730 NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817 		JBrowse link
G Ralgds ral guanine nucleotide dissociation stimulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RALGDS mRNA CTD PMID:17183730 NCBI chr 3:11,839,686...11,880,059
Ensembl chr 3:11,839,416...11,880,059 		JBrowse link
G Ralgps1 Ral GEF with PH domain and SH3 binding motif 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RALGPS1 mRNA CTD PMID:17183730 NCBI chr 3:16,433,323...16,670,276
Ensembl chr 3:16,433,742...16,669,972 		JBrowse link
G Ramp2 receptor activity modifying protein 2 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP2 protein] CTD PMID:16326922 NCBI chr10:86,187,366...86,190,692 JBrowse link
G Ramp3 receptor activity modifying protein 3 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP3 protein] CTD PMID:16326922 NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902 		JBrowse link
G Rap1a RAP1A, member of RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAP1A mRNA CTD PMID:17183730 NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501 		JBrowse link
G Rarb retinoic acid receptor, beta decreases methylation ISO Hydralazine results in decreased methylation of RARB promoter CTD PMID:15862127 NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288 		JBrowse link
G Rbl1 RB transcriptional corepressor like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA CTD PMID:17183730 NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330 		JBrowse link
G Rbm22 RNA binding motif protein 22 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RBM22 mRNA CTD PMID:17183730 NCBI chr18:54,013,374...54,024,182
Ensembl chr18:54,013,351...54,024,569 		JBrowse link
G Rbm4 RNA binding motif protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RBM4 mRNA CTD PMID:17183730 NCBI chr 1:202,078,442...202,087,506
Ensembl chr 1:202,085,279...202,105,380 		JBrowse link
G Rcl1 RNA terminal phosphate cyclase-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RCL1 mRNA CTD PMID:17183730 NCBI chr 1:226,824,524...226,869,046
Ensembl chr 1:226,824,534...226,902,315 		JBrowse link
G Reep4 receptor accessory protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of REEP4 mRNA CTD PMID:17183730 NCBI chr15:45,620,317...45,623,524
Ensembl chr15:45,619,941...45,623,526 		JBrowse link
G Reg1a regenerating family member 1 alpha multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of REG1A mRNA CTD PMID:17183730 NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO Hydralazine inhibits the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]] CTD PMID:27238871 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Ren renin multiple interactions
increases activity
increases expression		 ISO
EXP		 Alprenolol inhibits the reaction [Hydralazine results in increased expression of REN protein]
Hydralazine results in increased activity of REN protein		 CTD PMID:231700 PMID:923630 PMID:2203898 PMID:2953239 PMID:3154321 NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489 		JBrowse link
G Rer1 retention in endoplasmic reticulum sorting receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RER1 mRNA CTD PMID:17183730 NCBI chr 5:165,634,567...165,646,643
Ensembl chr 5:165,634,300...165,646,750 		JBrowse link
G Rfx1 regulatory factor X1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RFX1 mRNA CTD PMID:17183730 NCBI chr19:24,061,336...24,092,044
Ensembl chr19:24,061,336...24,092,044 		JBrowse link
G RGD1561662 similar to AI661453 protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C6ORF132 mRNA CTD PMID:17183730 NCBI chr 9:13,524,822...13,561,756
Ensembl chr 9:13,525,395...13,561,585 		JBrowse link
G Rgs7bp regulator of G-protein signaling 7 binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RGS7BP mRNA CTD PMID:17183730 NCBI chr 2:36,133,944...36,231,505
Ensembl chr 2:36,139,201...36,231,505 		JBrowse link
G Rgs9 regulator of G-protein signaling 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RGS9 mRNA CTD PMID:17183730 NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892 		JBrowse link
G Rgs9bp regulator of G protein signaling 9 binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RGS9BP mRNA CTD PMID:17183730 NCBI chr 1:88,249,438...88,250,151
Ensembl chr 1:88,249,438...88,250,151 		JBrowse link
G Rin3 Ras and Rab interactor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RIN3 mRNA CTD PMID:17183730 NCBI chr 6:121,431,803...121,540,957
Ensembl chr 6:121,431,339...121,540,957 		JBrowse link
G Rinl Ras and Rab interactor-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RINL mRNA CTD PMID:17183730 NCBI chr 1:84,077,011...84,088,590
Ensembl chr 1:84,077,265...84,088,330 		JBrowse link
G Ripk1 receptor interacting serine/threonine kinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA CTD PMID:17183730 NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824 		JBrowse link
G Ripply1 ripply transcriptional repressor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPPLY1 mRNA CTD PMID:17183730 NCBI chr  X:103,436,731...103,440,904
Ensembl chr  X:103,436,729...103,443,349 		JBrowse link
G Rmnd5b required for meiotic nuclear division 5 homolog B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RMND5B mRNA CTD PMID:17183730 NCBI chr10:35,881,250...35,892,322
Ensembl chr10:35,881,268...35,892,265 		JBrowse link
G Rnf152 ring finger protein 152 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RNF152 mRNA CTD PMID:17183730 NCBI chr13:21,324,039...21,403,405
Ensembl chr13:21,323,824...21,403,113 		JBrowse link
G Rnf187 ring finger protein 187 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RNF187 mRNA CTD PMID:17183730 NCBI chr10:43,709,493...43,715,392
Ensembl chr10:43,702,357...43,716,157 		JBrowse link
G Robo2 roundabout guidance receptor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ROBO2 mRNA CTD PMID:17183730 NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536 		JBrowse link
G Romo1 reactive oxygen species modulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ROMO1 mRNA CTD PMID:17183730 NCBI chr 3:144,659,709...144,661,310
Ensembl chr 3:144,659,826...144,661,310 		JBrowse link
G Rpl10a ribosomal protein L10A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL10A mRNA CTD PMID:17183730 NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357 		JBrowse link
G Rpl13 ribosomal protein L13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL13 mRNA CTD PMID:17183730 NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014 		JBrowse link
G Rpl17 ribosomal protein L17 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL17 mRNA CTD PMID:17183730 NCBI chr18:68,581,147...68,584,253
Ensembl chr18:68,581,098...68,584,253 		JBrowse link
G Rpl18a ribosomal protein L18A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA CTD PMID:17183730 NCBI chr16:18,542,572...18,544,578
Ensembl chr16:18,542,566...18,545,546 		JBrowse link
G Rpl23a ribosomal protein L23a multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA CTD PMID:17183730 NCBI chr10:63,076,660...63,079,346
Ensembl chr10:63,076,066...63,079,346 		JBrowse link
G Rpl24 ribosomal protein L24 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL24 mRNA CTD PMID:17183730 NCBI chr11:44,653,937...44,659,346
Ensembl chr11:44,653,937...44,659,370 		JBrowse link
G Rpl26 ribosomal protein L26 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL26 mRNA CTD PMID:17183730 NCBI chr10:53,610,836...53,613,966
Ensembl chr10:53,610,421...53,613,966 		JBrowse link
G Rpl27 ribosomal protein L27 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL27 mRNA CTD PMID:17183730 NCBI chr10:86,375,511...86,379,210
Ensembl chr10:86,375,454...86,379,193 		JBrowse link
G Rpl31 ribosomal protein L31 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL31 mRNA CTD PMID:17183730 NCBI chr 9:41,647,401...41,650,886
Ensembl chr 9:41,647,426...41,662,129 		JBrowse link
G Rpl34 ribosomal protein L34 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL34 mRNA CTD PMID:17183730 NCBI chr 2:219,284,373...219,288,108
Ensembl chr 2:219,284,382...219,288,111 		JBrowse link
G Rpl36 ribosomal protein L36 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL36 mRNA CTD PMID:17183730 NCBI chr 9:1,441,986...1,447,397 JBrowse link
G Rpl37a ribosomal protein L37a multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL37A mRNA CTD PMID:17183730
G Rpl39 ribosomal protein L39 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL39 mRNA CTD PMID:17183730 NCBI chr  X:116,327,183...116,330,211 JBrowse link
G Rpl41 ribosomal protein L41 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL41 mRNA CTD PMID:17183730 NCBI chr 7:977,885...978,965 JBrowse link
G Rpl7 ribosomal protein L7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL7 mRNA CTD PMID:17183730 NCBI chr 5:3,217,184...3,220,192 JBrowse link
G Rplp1 ribosomal protein lateral stalk subunit P1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPLP1 mRNA CTD PMID:17183730 NCBI chr 8:62,394,008...62,395,341
Ensembl chr 8:62,393,177...62,395,339 		JBrowse link
G Rpp21 ribonuclease P/MRP subunit p21 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPP21 mRNA CTD PMID:17183730 NCBI chr20:2,018,170...2,020,100
Ensembl chr20:2,018,147...2,020,106 		JBrowse link
G Rps11 ribosomal protein S11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS11 mRNA CTD PMID:17183730 NCBI chr 1:95,605,690...95,607,798
Ensembl chr 1:95,605,692...95,607,874 		JBrowse link
G Rps12 ribosomal protein S12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS12 mRNA CTD PMID:17183730 NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014 		JBrowse link
G Rps19bp1 ribosomal protein S19 binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS19BP1 mRNA CTD PMID:17183730 NCBI chr 7:111,812,129...111,812,751
Ensembl chr 7:111,809,355...111,812,757 		JBrowse link
G Rps2 ribosomal protein S2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS2 mRNA CTD PMID:17183730 NCBI chr10:13,747,316...13,749,165
Ensembl chr10:13,747,301...13,749,163 		JBrowse link
G Rps27 ribosomal protein S27 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS27 mRNA CTD PMID:17183730 NCBI chr 2:175,665,858...175,666,963
Ensembl chr 2:175,665,853...175,666,964 		JBrowse link
G Rps27a ribosomal protein S27a multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS27A mRNA CTD PMID:17183730 NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 		JBrowse link
G Rps6ka5 ribosomal protein S6 kinase A5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA CTD PMID:17183730 NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224 		JBrowse link
G Rps9 ribosomal protein S9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS9 mRNA CTD PMID:17183730
G Rspo4 R-spondin 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RSPO4 mRNA CTD PMID:17183730 NCBI chr 3:140,357,256...140,391,780
Ensembl chr 3:140,357,424...140,388,254 		JBrowse link
G Rsrp1 arginine and serine rich protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RSRP1 mRNA CTD PMID:17183730 NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523 		JBrowse link
G RT1-DOb RT1 class II, locus DOb multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-DOB mRNA CTD PMID:17183730 NCBI chr20:4,619,599...4,625,627
Ensembl chr20:4,619,816...4,625,667 		JBrowse link
G Rtn4rl1 reticulon 4 receptor-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RTN4RL1 mRNA CTD PMID:17183730 NCBI chr10:60,043,246...60,116,977
Ensembl chr10:60,043,002...60,116,978 		JBrowse link
G Rwdd1 RWD domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RWDD1 mRNA CTD PMID:17183730 NCBI chr20:25,949,723...25,967,147
Ensembl chr20:25,941,966...25,967,193 		JBrowse link
G Rxrg retinoid X receptor gamma multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RXRG mRNA CTD PMID:17183730 NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167 		JBrowse link
G S100a6 S100 calcium binding protein A6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of S100A6 mRNA CTD PMID:17183730 NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180 		JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of S100A8 mRNA CTD PMID:17183730 NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643 		JBrowse link
G S100pbp S100P binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of S100PBP mRNA CTD PMID:17183730 NCBI chr 5:141,494,352...141,535,752
Ensembl chr 5:141,494,353...141,535,525 		JBrowse link
G Samd4a sterile alpha motif domain containing 4A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SAMD4A mRNA CTD PMID:17183730 NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380 		JBrowse link
G Samm50 SAMM50 sorting and assembly machinery component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SAMM50 mRNA CTD PMID:17183730 NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682 		JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SARAF mRNA CTD PMID:17183730 NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545 		JBrowse link
G Scap SREBF chaperone multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCAP mRNA CTD PMID:17183730 NCBI chr 8:110,306,031...110,360,677
Ensembl chr 8:110,306,031...110,360,666 		JBrowse link
G Scarf1 scavenger receptor class F, member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCARF1 mRNA CTD PMID:17183730 NCBI chr10:60,359,213...60,371,516
Ensembl chr10:60,359,197...60,371,516 		JBrowse link
G Scml1 Scm polycomb group protein like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SCML1 mRNA CTD PMID:17183730 NCBI chr  X:32,893,100...32,912,686 JBrowse link
G Scnn1b sodium channel epithelial 1 subunit beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCNN1B mRNA CTD PMID:17183730 NCBI chr 1:176,430,063...176,484,451
Ensembl chr 1:176,430,103...176,484,451 		JBrowse link
G Scrn2 secernin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCRN2 mRNA CTD PMID:17183730 NCBI chr10:82,016,604...82,020,676
Ensembl chr10:82,016,649...82,020,675 		JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SDF2L1 mRNA CTD PMID:17183730 NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902 		JBrowse link
G Sdhaf3 succinate dehydrogenase complex assembly factor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SDHAF3 mRNA CTD PMID:17183730 NCBI chr 4:35,143,131...35,160,416
Ensembl chr 4:35,100,506...35,160,749 		JBrowse link
G Sec11c SEC11 homolog C, signal peptidase complex subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEC11C mRNA CTD PMID:17183730 NCBI chr18:59,320,932...59,337,272
Ensembl chr18:59,320,884...59,337,364 		JBrowse link
G Sec31a SEC31 homolog A, COPII coat complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEC31A mRNA CTD PMID:17183730 NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273 		JBrowse link
G Selenow selenoprotein W multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SELENOW mRNA CTD PMID:17183730 NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724
Ensembl chr 1:76,598,779...76,604,724 		JBrowse link
G Selplg selectin P ligand multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SELPLG mRNA CTD PMID:17183730 NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585 		JBrowse link
G Sema4a semaphorin 4A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEMA4A mRNA CTD PMID:17183730 NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442 		JBrowse link
G Septin2 septin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEPTIN2 mRNA CTD PMID:17183730 NCBI chr 9:94,018,141...94,051,386
Ensembl chr 9:94,018,208...94,051,386 		JBrowse link
G Serp2 stress-associated endoplasmic reticulum protein family member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SERP2 mRNA CTD PMID:17183730 NCBI chr15:51,879,884...51,903,965
Ensembl chr15:51,879,877...51,904,785 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions
decreases expression		 EXP [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein
Hydralazine results in decreased expression of SERPINE1 mRNA		 CTD PMID:11318962 PMID:23415681 NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657 		JBrowse link
G Serping1 serpin family G member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SERPING1 mRNA CTD PMID:17183730 NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034 		JBrowse link
G Sertad2 SERTA domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SERTAD2 mRNA CTD PMID:17183730 NCBI chr14:94,733,637...94,838,200
Ensembl chr14:94,733,579...94,838,313 		JBrowse link
G Sf1 splicing factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SF1 mRNA CTD PMID:17183730 NCBI chr 1:203,670,016...203,683,432
Ensembl chr 1:203,670,018...203,684,330 		JBrowse link
G Sf3b6 splicing factor 3B, subunit 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SF3B6 mRNA CTD PMID:17183730 NCBI chr 6:27,826,044...27,835,086
Ensembl chr 6:27,826,029...27,835,156 		JBrowse link
G Shank2 SH3 and multiple ankyrin repeat domains 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SHANK2 mRNA CTD PMID:17183730 NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394 		JBrowse link
G Shisa2 shisa family member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SHISA2 mRNA CTD PMID:17183730 NCBI chr15:33,806,715...33,811,013
Ensembl chr15:33,805,958...33,811,013 		JBrowse link
G Shoc1 shortage in chiasmata 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SHOC1 mRNA CTD PMID:17183730 NCBI chr 5:73,864,423...73,956,487 JBrowse link
G Shox2 short stature homeobox 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SHOX2 mRNA CTD PMID:17183730 NCBI chr 2:151,217,049...151,227,180
Ensembl chr 2:151,217,552...151,227,143 		JBrowse link
G Sidt2 SID1 transmembrane family, member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SIDT2 mRNA CTD PMID:17183730 NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700 		JBrowse link
G Sipa1l1 signal-induced proliferation-associated 1 like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SIPA1L1 mRNA CTD PMID:17183730 NCBI chr 6:101,839,351...102,118,408
Ensembl chr 6:101,839,404...102,116,950 		JBrowse link
G Ski SKI proto-oncogene multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SKI mRNA CTD PMID:17183730 NCBI chr 5:165,713,525...165,782,134
Ensembl chr 5:165,714,093...165,782,733 		JBrowse link
G Slc12a3 solute carrier family 12 member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC12A3 mRNA CTD PMID:17183730 NCBI chr19:10,630,649...10,679,250
Ensembl chr19:10,631,393...10,669,091 		JBrowse link
G Slc16a2 solute carrier family 16 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC16A2 mRNA CTD PMID:17183730 NCBI chr  X:68,725,365...68,848,572
Ensembl chr  X:68,723,261...68,848,771 		JBrowse link
G Slc17a9 solute carrier family 17 member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC17A9 mRNA CTD PMID:17183730 NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985 		JBrowse link
G Slc19a2 solute carrier family 19 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC19A2 mRNA CTD PMID:17183730 NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172 		JBrowse link
G Slc22a16 solute carrier family 22 member 16 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC22A16 mRNA CTD PMID:17183730 NCBI chr20:43,972,808...44,068,447 JBrowse link
G Slc22a17 solute carrier family 22, member 17 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC22A17 mRNA CTD PMID:17183730 NCBI chr15:28,382,285...28,389,435
Ensembl chr15:28,382,292...28,388,799 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Hydralazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268 		JBrowse link
G Slc23a3 solute carrier family 23, member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC23A3 mRNA CTD PMID:17183730 NCBI chr 9:76,622,621...76,633,188
Ensembl chr 9:76,622,800...76,631,366 		JBrowse link
G Slc25a13 solute carrier family 25 member 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC25A13 mRNA CTD PMID:17183730 NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902 		JBrowse link
G Slc25a5 solute carrier family 25 member 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC25A5 mRNA CTD PMID:17183730 NCBI chr  X:116,031,896...116,034,963
Ensembl chr  X:116,031,803...116,034,967 		JBrowse link
G Slc2a9 solute carrier family 2 member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC2A9 mRNA CTD PMID:17183730 NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981 		JBrowse link
G Slc30a2 solute carrier family 30 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC30A2 mRNA CTD PMID:17183730 NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956 		JBrowse link
G Slc35c1 solute carrier family 35 member C1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC35C1 mRNA CTD PMID:17183730 NCBI chr 3:78,421,925...78,429,603
Ensembl chr 3:78,421,933...78,428,520 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC3A2 mRNA CTD PMID:17183730 NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931 		JBrowse link
G Slc6a13 solute carrier family 6 member 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A13 mRNA CTD PMID:17183730 NCBI chr 4:154,539,246...154,577,784
Ensembl chr 4:154,540,468...154,576,152 		JBrowse link
G Slc6a2 solute carrier family 6 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A2 mRNA CTD PMID:17183730 NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357 		JBrowse link
G Slc8b1 solute carrier family 8 member B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC8B1 mRNA CTD PMID:17183730 NCBI chr12:36,029,759...36,053,087
Ensembl chr12:36,029,760...36,053,031 		JBrowse link
G Slirp SRA stem-loop interacting RNA binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLIRP mRNA CTD PMID:17183730 NCBI chr 6:107,088,760...107,097,791
Ensembl chr 6:107,088,403...107,097,791 		JBrowse link
G Smarcc1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SMARCC1 mRNA CTD PMID:17183730 NCBI chr 8:110,111,097...110,214,727
Ensembl chr 8:110,111,122...110,214,720 		JBrowse link
G Smo smoothened, frizzled class receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SMO mRNA CTD PMID:17183730 NCBI chr 4:58,344,101...58,372,828
Ensembl chr 4:58,343,529...58,373,829 		JBrowse link
G Smurf2 SMAD specific E3 ubiquitin protein ligase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SMURF2 mRNA CTD PMID:17183730 NCBI chr10:91,761,798...91,862,485
Ensembl chr10:91,761,807...91,862,488 		JBrowse link
G Snai3 snail family transcriptional repressor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNAI3 mRNA CTD PMID:17183730 NCBI chr19:50,516,771...50,529,295
Ensembl chr19:50,516,771...50,523,486 		JBrowse link
G Snf8 SNF8 subunit of ESCRT-II multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNF8 mRNA CTD PMID:17183730 NCBI chr10:80,984,337...80,996,724
Ensembl chr10:80,984,363...80,996,734 		JBrowse link
G Snrnp70 small nuclear ribonucleoprotein U1 subunit 70 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRNP70 mRNA CTD PMID:17183730 NCBI chr 1:95,856,039...95,876,434
Ensembl chr 1:95,856,036...95,876,392 		JBrowse link
G Snrpb small nuclear ribonucleoprotein polypeptides B and B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPB mRNA CTD PMID:17183730 NCBI chr 3:117,369,816...117,379,344
Ensembl chr 3:117,370,100...117,379,339 		JBrowse link
G Snrpb2 small nuclear ribonucleoprotein polypeptide B2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPB2 mRNA CTD PMID:17183730 NCBI chr 3:130,399,239...130,408,821
Ensembl chr 3:130,399,248...130,408,812 		JBrowse link
G Snrpd2 small nuclear ribonucleoprotein D2 polypeptide multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPD2 mRNA CTD PMID:17183730 NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351 		JBrowse link
G Snrpg small nuclear ribonucleoprotein polypeptide G multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPG mRNA CTD PMID:17183730 NCBI chr 4:118,812,278...118,819,827
Ensembl chr 4:118,812,252...118,819,826 		JBrowse link
G Snu13 small nuclear ribonucleoprotein 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNU13 mRNA CTD PMID:17183730 NCBI chr 7:113,565,903...113,570,871
Ensembl chr 7:113,565,295...113,570,872 		JBrowse link
G Sox1 SRY-box transcription factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SOX1 mRNA CTD PMID:17183730 NCBI chr16:77,134,795...77,139,628 JBrowse link
G Sox9 SRY-box transcription factor 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SOX9 mRNA CTD PMID:17183730 NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994 		JBrowse link
G Spdef SAM pointed domain containing ets transcription factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SPDEF mRNA CTD PMID:17183730 NCBI chr20:5,771,434...5,786,793
Ensembl chr20:5,771,441...5,785,893 		JBrowse link
G Spint1 serine peptidase inhibitor, Kunitz type 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SPINT1 mRNA CTD PMID:17183730 NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119 		JBrowse link
G Sprr1a small proline-rich protein 1A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SPRR1A mRNA CTD PMID:17183730 NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063 		JBrowse link
G Sprr1b small proline-rich protein 1B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SPRR1B mRNA CTD PMID:17183730 NCBI chr 2:178,009,130...178,009,567
Ensembl chr 2:178,009,130...178,009,567 		JBrowse link
G Spsb2 splA/ryanodine receptor domain and SOCS box containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SPSB2 mRNA CTD PMID:17183730 NCBI chr 4:157,612,921...157,615,293
Ensembl chr 4:157,613,401...157,615,284 		JBrowse link
G Srp72 signal recognition particle 72 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRP72 mRNA CTD PMID:17183730 NCBI chr14:31,168,175...31,195,717 JBrowse link
G Srp9 signal recognition particle 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRP9 mRNA CTD PMID:17183730 NCBI chr13:93,832,580...93,840,720
Ensembl chr13:93,832,580...93,840,720 		JBrowse link
G Srpk3 SRSF protein kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRPK3 mRNA CTD PMID:17183730 NCBI chr  X:151,510,452...151,515,208
Ensembl chr  X:151,510,539...151,515,198 		JBrowse link
G Srxn1 sulfiredoxin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRXN1 mRNA CTD PMID:17183730 NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448 		JBrowse link
G Ssbp4 single stranded DNA binding protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SSBP4 mRNA CTD PMID:17183730 NCBI chr16:18,828,014...18,838,941
Ensembl chr16:18,828,054...18,838,947 		JBrowse link
G